VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaxlert: Peer-reviewed Vaccine Publications in Last Month

From Mar 01, 2024 To Mar 31, 2024 :


Bacillus anthracis (Anthrax)

  1. Tullius MV, Bowen RA, Back PS, Masleša-Galić S, Nava S, Horwitz MA. LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice mBio 15(4):e0018624 2024 [PMID: 38511933]
  2. Williams B, Paterson J, Rawsthorne-Manning HJ, Jeffrey PA, Gillard JJ, Lythe G, Laws TR, López-García M. Quantifying in vitro B. anthracis growth and PA production and decay: a mathematical modelling approach NPJ systems biology and applications 10(1):33 2024 [PMID: 38553532]
  3. Benn JS, Nunez CM, Blue-McLendon A, Chaki SP, Ficht TA, Rice-Ficht AC, Cook WE. LETHAL TOXIN NEUTRALIZING ANTIBODY RESPONSE INDUCED FOLLOWING ORAL VACCINATION WITH A MICROENCAPSULATED BACILLUS ANTHRACIS STERNE STRAIN 34F2 VACCINE PROOF-OF-CONCEPT STUDY IN WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS) Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 55(1):212-218 2024 [PMID: 38453505]

Brucella (Brucellosis)

  1. Cabello AL, Wells K, Peng W, Feng HQ, Wang J, Meyer DF, Noroy C, Zhao ES, Zhang H, Li X, Chang H, Gomez G, Mao Y, Patrick KL, Watson RO, Russell WK, Yu A, Zhong J, Guo F, Li M, Zhou M, Qian X, Kobayashi KS, Song J, Panthee S, Mechref Y, Ficht TA, Qin QM, de Figueiredo P. Brucella-driven host N-glycome remodeling controls infection Cell host & microbe 32(4):588-605.e9 2024 [PMID: 38531364]
  2. Abbasi-Ghahramanloo A, Ebrahimoghli R, Ebrahimnejad M, Gholizadeh N, Moradi-Asl E. Knowledge, attitudes, and practices regarding brucellosis in a rural population: A cross-sectional study Heliyon 10(6):e28041 2024 [PMID: 38545216]
  3. Shi J, Zhu Y, Yin Z, He Y, Li Y, Haimiti G, Xie X, Niu C, Guo W, Zhang F. In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD Scientific reports 14(1):7278 2024 [PMID: 38538674]
  4. Parsons MG, Hermelin D, Hennenfent A, Tiller RV, Annambhotla P, Negrón ME, Basavaraju SV, Katz LM. Animal vaccine strain Brucella abortus infection in a plateletpheresis donor: A case report Transfusion 2024 [PMID: 38501889]
  5. Yu H, Gu X, Wang D, Wang Z. Brucella infection and Toll-like receptors Frontiers in cellular and infection microbiology 14:1342684 2024 [PMID: 38533384]
  6. López Vásquez IA, Palomares Resendiz EG, Gutiérrez Hernández JL, Garrido Fariña GI, Tórtora Pérez JL, de Jesús Olmos Espejel J, Hernández Castro R, Sangari F, Suárez Güemes F, Díaz Aparicio E. Effects of vaccination with Brucella melitensis, strains Rev 1 ΔeryCD and Rev 1, on the reproductive system of young male goats Revista Argentina de microbiologia 2024 [PMID: 38453565]

Burkholderia mallei (Glanders)

  1. Badten AJ, Torres AG. Burkholderia pseudomallei Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to Burkholderia cepacia Complex Vaccines 12(3) 2024 [PMID: 38543947]

Burkholderia pseudomallei (Melioidosis)

  1. Tullius MV, Bowen RA, Back PS, Masleša-Galić S, Nava S, Horwitz MA. LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice mBio 15(4):e0018624 2024 [PMID: 38511933]
  2. Tantirat P, Chantarawichian Y, Taweewigyakarn P, Kripattanapong S, Jitpeera C, Doungngern P, Phiancharoen C, Tangwangvivat R, Hinjoy S, Sujariyakul A, Amornchai P, Wongsuvan G, Hantakun V, Wuthiekanun V, Thaipadungpanit J, Thomson NR, Dance DAB, Chewapreecha C, Batty EM, Limmathurotsakul D. Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021 Emerging infectious diseases 30(4):791-794 2024 [PMID: 38526300]
  3. Badten AJ, Torres AG. Burkholderia pseudomallei Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to Burkholderia cepacia Complex Vaccines 12(3) 2024 [PMID: 38543947]

Clostridium botulinum toxin (Botulism)

  1. Sangprasat K, Bulaon CJI, Rattanapisit K, Srisangsung T, Jirarojwattana P, Wongwatanasin A, Phoolcharoen W. Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana Human vaccines & immunotherapeutics 20(1):2329446 2024 [PMID: 38525945]

Coxiella burnetii (Q fever)

  1. Hsueh YL, Chen HF, Chang MC, Yen TY, Su CL, Chiu HC, Hu HC, Chung YT, Shu PY, Yang SL. Epidemiology of Murine Typhus in Taiwan from 2013 to 2020 The American journal of tropical medicine and hygiene 110(4):768-778 2024 [PMID: 38471176]
  2. Forouharmehr A. Whole proteome screening to develop a potent epitope-based vaccine against Coxiella burnetii: a reverse vaccinology approach Journal of biomolecular structure & dynamics :1-13 2024 [PMID: 38488603]
  3. Toledo-Perona R, Contreras A, Gomis J, Quereda JJ, García-Galán A, Sánchez A, Gómez-Martín Á. Controlling Coxiella burnetii in naturally infected sheep, goats and cows, and public health implications: a scoping review Frontiers in veterinary science 11:1321553 2024 [PMID: 38425838]

Eastern equine encephalitis virus

  1. Fierro C, Weidenthaler H, Vidojkovic S, Schmidt D, Gafoor Z, Stroukova D, Zwiers S, Müller J, Volkmann A. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial Vaccine 42(10):2695-2706 2024 [PMID: 38494412]

Ebola virus

  1. Goldstein N, McLean C, Gaddah A, Doua J, Keshinro B, Bus-Jacobs L, Hendriks J, Luhn K, Robinson C, Douoguih M. Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial Human vaccines & immunotherapeutics 20(1):2327747 2024 [PMID: 38523332]
  2. Felgner J, Clarke E, Hernandez-Davies JE, Jan S, Wirchnianski AS, Jain A, Nakajima R, Jasinskas A, Strahsburger E, Chandran K, Bradfute S, Davies DH. Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines Antiviral research 225:105851 2024 [PMID: 38458540]
  3. Bus-Jacobs L, Lau R, Soethoudt M, Gebbia L, Janssens E, Hermans T. Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions(1) Emerging infectious diseases 30(4):757-760 2024 [PMID: 38526137]
  4. Happe M, Hofstetter AR, Wang J, Yamshchikov GV, Holman LA, Novik L, Strom L, Kiweewa F, Wakabi S, Millard M, Kelley CF, Kabbani S, Edupuganti S, Beck A, Kaltovich F, Murray T, Tsukerman S, Carr D, Ashman C, Stanley DA, Ploquin A, Bailer RT, Schwartz R, Cham F, Tindikahwa A, Hu Z, Gordon IJ, Rouphael N, Houser KV, Coates EE, Graham BS, Koup RA, Mascola JR, Sullivan NJ, Robb ML, Ake JA, Lyke KE, Mulligan MJ, Ledgerwood JE, Kibuuka H. Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials NPJ vaccines 9(1):67 2024 [PMID: 38553525]
  5. Larivière Y, Matuvanga TZ, Osang'ir BI, Milolo S, Meta R, Kimbulu P, Robinson C, Katwere M, McLean C, Lemey G, Matangila J, Maketa V, Mitashi P, Van Geertruyden JP, Van Damme P, Muhindo-Mavoko H. Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial The Lancet. Infectious diseases 2024 [PMID: 38552653]
  6. Zhang Y, Zhang M, Wu H, Wang X, Zheng H, Feng J, Wang J, Luo L, Xiao H, Qiao C, Li X, Zheng Y, Huang W, Wang Y, Wang Y, Shi Y, Feng J, Chen G. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus eLife 12 2024 [PMID: 38526940]
  7. Motsa BB, Sharma T, Ciofi M, Chapagain PP, Stahelin RV. Minor electrostatic changes robustly increase VP40 membrane binding, assembly, and budding of Ebola virus matrix protein derived virus-like particles The Journal of biological chemistry :107213 2024 [PMID: 38522519]
  8. Charnley GEC, Green N, Kelman I, Malembaka EB, Gaythorpe KAM. Evaluating the risk of conflict on recent Ebola outbreaks in Guinea and the Democratic Republic of the Congo BMC public health 24(1):860 2024 [PMID: 38509557]
  9. El Ayoubi LW, Mahmoud O, Zakhour J, Kanj SS. Recent advances in the treatment of Ebola disease: A brief overview PLoS pathogens 20(3):e1012038 2024 [PMID: 38489257]
  10. Prasad AN, Geisbert TW. A glass-half-full perspective on negative data in Ebolavirus vaccine studies The Journal of infectious diseases 2024 [PMID: 38488013]
  11. van Tol S, Fletcher P, Feldmann F, Mukesh RK, Port JR, Gallogly S, Schulz JE, Rhoderick JF, Makinson R, Carmody A, Myers L, Lovaglio J, Smith BJ, Okumura A, Shaia C, Saturday G, Marzi A, Lambe T, Munster VJ, van Doremalen N. A bivalent Adenovirus-Vectored Vaccine induces a robust humoral response, but does not protect cynomolgus macaques against a lethal challenge with Sudan virus The Journal of infectious diseases 2024 [PMID: 38487996]
  12. Wang M, Wu J, Cao X, Xu L, Wu J, Ding H, Shang Y. Developments in Negative-Strand RNA Virus Reverse Genetics Microorganisms 12(3) 2024 [PMID: 38543609]
  13. . Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Lancet (London, England) 2024 [PMID: 38484753]
  14. Mitu RA, Islam MR. The Current Pathogenicity and Potential Risk Evaluation of Marburg Virus to Cause Mysterious "Disease X"-An Update on Recent Evidences Environmental health insights 18:11786302241235809 2024 [PMID: 38440221]
  15. Stephens MT, Juniastuti, Sulistiawati, Dossen PC. The potential risk components and prevention measures of the Ebola virus disease outbreak in Liberia: An in-depth interview with the health workers and stakeholders Belitung nursing journal 10(1):67-77 2024 [PMID: 38425680]
  16. Yeh C, Huang C, Huang Y, Hartley CD, Fashina T, Ashby N, Miller C, Shantha JG, Justin GA, Chan RVP, Mattia JG, Vandy MJ, Harrison-Williams L, Mustapha J, Mwanza JC, Yeh S. Childhood vision impairment and blindness in West Africa: public health measures and implications for systemic health Frontiers in medicine 11:1349093 2024 [PMID: 38439905]

Escherichia coli

  1. Lu W, Lu H, Huo X, Wang C, Zhang Z, Zong B, Wang G, Dong W, Li X, Li Y, Chen H, Tan C. EvfG is a multi-function protein located in the Type VI secretion system for ExPEC Microbiological research 283:127647 2024 [PMID: 38452551]
  2. Cárdenas-Guerra RE, Montes-Flores O, Nava-Pintor EE, Reséndiz-Cardiel G, Flores-Pucheta CI, Rodríguez-Gavaldón YI, Arroyo R, Bottazzi ME, Hotez PJ, Ortega-López J. Chagasin from Trypanosoma cruzi as a molecular scaffold to express epitopes of TSA-1 as soluble recombinant chimeras Protein expression and purification 218:106458 2024 [PMID: 38423156]
  3. Salauddin M, Kayesh MEH, Ahammed MS, Saha S, Hossain MG. Development of membrane protein-based vaccine against lumpy skin disease virus (LSDV) using immunoinformatic tools Veterinary medicine and science 10(3):e1438 2024 [PMID: 38555573]
  4. Zhang C, Wei G, Zhou N, Wang Y, Feng J, Wang X, Zhang A, Chen K. Systematic Engineering of Escherichia coli for Efficient Production of Pseudouridine from Glucose and Uracil ACS synthetic biology 13(4):1303-1311 2024 [PMID: 38529630]
  5. Wang Y, Xu F, Yuan C, Zhang Y, Ren J, Yue H, Ma T, Song Q. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells Vaccine 42(11):2848-2857 2024 [PMID: 38514351]
  6. Wu J, Jiang L, Shao Q, Liu J, Wang H, Gao Q, Huan C, Wang X, Gao S. Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge Vaccine 42(10):2707-2715 2024 [PMID: 38503663]
  7. Li M, Zhao D, Guo J, Pan T, Niu T, Jiang Y, Shi C, Huang H, Wang N, Zhang D, Zhang S, Wang C, Yang G. Bacillus halotolerans SW207 alleviates enterotoxigenic Escherichia coli-induced inflammatory responses in weaned piglets by modulating the intestinal epithelial barrier, the TLR4/MyD88/NF-κB pathway, and intestinal microbiota Microbiology spectrum 12(4):e0398823 2024 [PMID: 38451226]
  8. Rimbi PT, O'Boyle N, Douce GR, Pizza M, Rosini R, Roe AJ. Enhancing a multi-purpose artificial urine for culture and gene expression studies of uropathogenic Escherichia coli strains Journal of applied microbiology 135(4) 2024 [PMID: 38486355]
  9. Shi J, Zhu Y, Yin Z, He Y, Li Y, Haimiti G, Xie X, Niu C, Guo W, Zhang F. In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD Scientific reports 14(1):7278 2024 [PMID: 38538674]
  10. Banesh S, Patil N, Chethireddy VR, Bhukmaria A, Saudagar P. Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets Medical oncology (Northwood, London, England) 41(5):90 2024 [PMID: 38522058]
  11. Torres-Sangiao E, Happonen L, Heusel M, Palm F, Gueto-Tettay C, Malmström L, Shannon O, Malmström J. Quantification of adaptive immune responses against protein binding interfaces in the streptococcal M1 protein Molecular & cellular proteomics : MCP :100753 2024 [PMID: 38527648]
  12. Paudel S, Apostolakos I, Vougat Ngom R, Tilli G, de Carvalho Ferreira HC, Piccirillo A. A systematic review and meta-analysis on the efficacy of vaccination against colibacillosis in broiler production PloS one 19(3):e0301029 2024 [PMID: 38517875]
  13. Sarnelli G, Del Re A, Palenca I, Franzin SB, Lu J, Seguella L, Zilli A, Pesce M, Rurgo S, Esposito G, Sanseverino W, Esposito G. Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 174:116441 2024 [PMID: 38518597]
  14. Nguyet LTY, Ounjai P, Ngamwongsatit N, Kaeoket K. The immune response of pregnant sow after vaccination with crude fimbriae (F4) extracts vaccine and immunoprotection of nursery pig against pathogenic E. coli (F4(+)ETEC) Acta tropica 254:107173 2024 [PMID: 38503364]
  15. Yamashita W, Ojima S, Tamura A, Azam AH, Kondo K, Yuancheng Z, Cui L, Shintani M, Suzuki M, Takahashi Y, Watashi K, Tsuneda S, Kiga K. Harnessing a T1 Phage-Derived Spanin for Developing Phage-Based Antimicrobial Development Biodesign research 6:0028 2024 [PMID: 38516182]
  16. Yan H, Peng Y, Zhang J, Peng R, Feng X, Su J, Yi H, Lu Y, Gao S, Liu J, Yang M, Liu X, Gao S, Chen Z. Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds Vaccine 42(8):2072-2080 2024 [PMID: 38423815]
  17. Chileshe C, Shawa M, Phiri N, Ndebe J, Khumalo CS, Nakajima C, Kajihara M, Higashi H, Sawa H, Suzuki Y, Muleya W, Hang'ombe BM. Detection of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae from Diseased Broiler Chickens in Lusaka District, Zambia Antibiotics (Basel, Switzerland) 13(3) 2024 [PMID: 38534694]
  18. Yu J, Fu J, Liu H, Kang C, Wang Z, Jin Y, Wu S, Li T, Yang R, Jin M, Chen H, Wang X. Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic Escherichia coli Vaccines 12(3) 2024 [PMID: 38543938]
  19. Kannan J, Pang KL, Ho YN, Hsu PH, Chen LL. A Comparison of the Antioxidant Potential and Metabolite Analysis of Marine Fungi Associated with the Red Algae Pterocladiella capillacea from Northern Taiwan Antioxidants (Basel, Switzerland) 13(3) 2024 [PMID: 38539869]
  20. Zhou Y, Huang H, Chen G, Yuan Q, Ren J, Wu J, Lin Y, Lin Z, Xu L. Promoting the healing of diabetic wounds with an antimicrobial gel containing AgNPs with anti-infective and anti-inflammatory properties Journal of biomaterials science. Polymer edition :1-22 2024 [PMID: 38460114]
  21. Kulkarni R, Maranholkar V, Nguyen N, Cirino PC, Willson RC, Varadarajan N. The efficient synthesis and purification of 2'3'- cGAMP from Escherichia coli Frontiers in microbiology 15:1345617 2024 [PMID: 38525075]
  22. Ghasemifar S, Chabak O, Piri-Gharaghie T, Doosti A. PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model Vaccine 2024 [PMID: 38453620]
  23. Ninyio N, Schmitt K, Sergon G, Nilsson C, Andersson S, Scherbak N. Correction: Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9 Microbial cell factories 23(1):75 2024 [PMID: 38448924]
  24. Lemos TJDS, Silva HGS, Previato JO, Mendonça-Previato L, Freitas EO, Barbosa AS, Franzolin MR, Santos LFD, Melo BS, Anjos GFD, Gonçalves RHN, Domingos MO. O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development International journal of molecular sciences 25(5) 2024 [PMID: 38474124]
  25. Hu N, Li W, Zhao Z, Chang Y, Wang C, Zhang Y. Preparation and immunogenicity evaluation of C-HapS-P6 fusion protein vaccine against nontypeable Haemophilus influenzae in mice International journal of medical microbiology : IJMM 314:151616 2024 [PMID: 38461565]
  26. Kay EJ, Dooda MK, Bryant JC, Reid AJ, Wren BW, Troutman JM, Jorgenson MA. Engineering Escherichia coli for increased Und-P availability leads to material improvements in glycan expression technology Microbial cell factories 23(1):72 2024 [PMID: 38429691]
  27. Wong-Arce A, Gonzalez-Ortega O, Romero-Maldonado A, Miranda-López A, García-Soto M, Farfán-Castro S, Betancourt-Mendiola L, Teeravechyan S, Srisutthisamphan K, Comas-García M, Solís Andrade KI, Rosales-Mendoza S. Production and Immunogenicity Assessment of LTp50: An Escherichia coli-Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein Pharmaceuticals (Basel, Switzerland) 17(3) 2024 [PMID: 38543088]
  28. Shahininejad H, Rahimi S, Karimi Torshizi MA, Arabkhazaeli F, Ayyari M, Behnamifar A, Abuali M, Grimes J. Comparing the effect of phytobiotic, coccidiostat, toltrazuril, and vaccine on the prevention and treatment of coccidiosis in broilers Poultry science 103(5):103596 2024 [PMID: 38471232]
  29. Mwape K, Mubanga C, Chilyabanyama ON, Chibesa K, Chisenga CC, Silwamba S, Randall A, Liang X, Barnard TG, Simuyandi M, Chilengi R. Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic Escherichia coli among Children in Zambia Participating in a Phase I Clinical Trial Microorganisms 12(3) 2024 [PMID: 38543471]
  30. Lam FW, Brown CA, Ronca SE. Recombinant Rod Domain of Vimentin Reduces SARS-CoV-2 Viral Replication by Blocking Spike Protein-ACE2 Interactions International journal of molecular sciences 25(5) 2024 [PMID: 38473724]

Francisella tularensis (Tularemia)

  1. Tullius MV, Bowen RA, Back PS, Masleša-Galić S, Nava S, Horwitz MA. LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice mBio 15(4):e0018624 2024 [PMID: 38511933]
  2. Harrell JE, Roy CJ, Gunn JS, McLachlan JB. Current vaccine strategies and novel approaches to combatting Francisella infection Vaccine 42(9):2171-2180 2024 [PMID: 38461051]
  3. Pavkova I, Bavlovic J, Kubelkova K, Stulik J, Klimentova J. Protective potential of outer membrane vesicles derived from a virulent strain of Francisella tularensis Frontiers in microbiology 15:1355872 2024 [PMID: 38533334]
  4. Dubrovina VI, Yur'eva OV, Pyatidesyatnikova AB, Starovoitova TP, Balakhonov SV. Dynamics of Changes in the cAMP/cGMP Concentration Ratio in the Thymus and Spleen of Laboratory Mice during Vaccination against Plague and Tularemia against the Background of Immunomodulation Bulletin of experimental biology and medicine 176(4):472-476 2024 [PMID: 38492103]

Hantavirus

  1. Zhou W, Dong Y, Si H, Yang C, Zhao J, Chen X, Ye Z. Visual analysis of global hemorrhagic fever with renal syndrome research from 1980 to 2022: Based on CiteSpace and VOSviewer Medicine 103(13):e37586 2024 [PMID: 38552094]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Shi G, Lin B, Pan H, He W, Zhong X. Using an extended information-motivation-behavioral skills model to explain HPV vaccination intention among men who have sex with men only and men who have sex with men and women Human vaccines & immunotherapeutics 20(1):2327150 2024 [PMID: 38465886]
  2. Li Y, Yang L, Yang LQ. Effects of intrinsically disordered regions in gp120 underlying HIV neutralization phenotypes Biochemical and biophysical research communications 709:149830 2024 [PMID: 38547606]
  3. Zachová K, Bartheldyová E, Hubatka F, Křupka M, Odehnalová N, Turánek Knötigová P, Vaškovicová N, Sloupenská K, Hromádka R, Paulovičová E, Effenberg R, Ledvina M, Raška M, Turánek J. The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan Carbohydrate polymers 332:121844 2024 [PMID: 38431385]
  4. Nematian M, Noormohammadi Z, Rahimi P, Irani S, Arefian E. Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: A promising approach to Combat viral mutants, with a focus on HIV-1 Biochemical and biophysical research communications 708:149769 2024 [PMID: 38518723]
  5. De Meyer A, Meuleman P. Preclinical animal models to evaluate therapeutic antiviral antibodies Antiviral research 225:105843 2024 [PMID: 38548022]
  6. Burdier FR, Waheed DE, Nedjai B, Steenbergen RDM, Poljak M, Baay M, Vorsters A, Van Keer S. DNA methylation as a triage tool for cervical cancer screening - A meeting report Preventive medicine reports 41:102678 2024 [PMID: 38524273]
  7. Cahill SR. Federal and State Policy Issues Affecting Lesbian, Gay, Bisexual, Transgender, and Queer Older Adults Clinics in geriatric medicine 40(2):357-366 2024 [PMID: 38521605]
  8. Mastrangelo A, Gama L, Cinque P. Strategies to target the central nervous system HIV reservoir Current opinion in HIV and AIDS 19(3):133-140 2024 [PMID: 38457227]
  9. Kassis G, Palshikar MG, Hilchey SP, Zand MS, Thakar J. Discrete-state models identify pathway specific B cell states across diseases and infections at single-cell resolution Journal of theoretical biology 583:111769 2024 [PMID: 38423206]
  10. Yang Q, Wang J, Chen Z. Conditional splicing system for tight control of viral overlapping genes Journal of virology 98(4):e0024224 2024 [PMID: 38446633]
  11. Ferrara P, Losa L, Mantovani LG, Ambrosioni J, Agüero F. Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression Journal of travel medicine 31(3) 2024 [PMID: 38438165]
  12. Cheung DH, Chen S, Fang Y, Sun F, Zhang Q, Yu FY, Mo PKH, Wang Z. Influences of mpox disease perceptions, sources and contents of information exposure on mpox vaccine uptake among gay, bisexual, and other men who have sex with men in Hong Kong, China Vaccine 42(9):2337-2346 2024 [PMID: 38480102]
  13. Meng L, Harris L, Shaw L, Lymon H, Reses H, Bell J, Lu PJ, Gibbs-Scharf L, Chorba T. Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged ≥ 12 years, United States, August 2021-October 2022 Vaccine 42(9):2122-2126 2024 [PMID: 38453621]
  14. Beavis AC, Dienger-Stambaugh K, Briggs K, Chen Z, Abraham M, Spearman P, He B. A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice Vaccine 42(9):2347-2356 2024 [PMID: 38443277]
  15. Yadegarynia D, Keyvanfar A, Keyvani H, Tehrani S, Sali S, Abolghasemi S. Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial Vaccine 42(9):2254-2259 2024 [PMID: 38423811]
  16. Kim M, Kim E. Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process Journal of medical virology 96(4):e29558 2024 [PMID: 38533898]
  17. Poondi N, Hou J, Michienzi SM, Patel M, Borgetti S, Badowski ME. Assessing Immunity to Hepatitis A and Hepatitis B Among Individuals in Custody Living With HIV Journal of correctional health care : the official journal of the National Commission on Correctional Health Care 30(2):107-112 2024 [PMID: 38526571]
  18. Doyle TJ, Gumke M, Stanek D, Moore J, Buck B, Locksmith T, Tomson K, Schmedes S, Churchwell G, Hubsmith SJ, Krishnamoorthy B, Poschman K, Danforth B, Chacreton D. Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021-2022 Emerging infectious diseases 30(4):633-643 2024 [PMID: 38526187]
  19. Liang Z, Tong J, Wu X, Liu S, Wu J, Yu Y, Zhang L, Zhao C, Lu Q, Nie J, Huang W, Wang Y. Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV system MedComm 5(4):e517 2024 [PMID: 38525106]
  20. . Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology 23(4):344-381 2024 [PMID: 38493795]
  21. Fresse A, Massy N, Fournier D, Pinel S, Beurrier M, Antoine ML, Petitpain N, Gillet P. Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic AIDS (London, England) 38(5):768-771 2024 [PMID: 38482909]
  22. Allard R, Leclerc P, Bergeron G, Cadieux G. Breakthrough cases of mpox: One-dose vaccination is associated with milder clinical manifestations Journal of infection and public health 17(4):676-680 2024 [PMID: 38461797]
  23. Farrell R, Zaunders J, Poynten IM, Anderson L, Evans L. Concurrent nonavalent human papillomavirus (HPV) vaccination and immune stimulation with imiquimod to treat recalcitrant HPV-associated high grade vaginal intra-epithelial neoplasia Gynecologic oncology reports 52:101350 2024 [PMID: 38445009]
  24. Juniour Nsubuga E, Kirabo J, Kwiringira A, Andaku L, Magona Nerima S, Nsubuga F, Nakazzi R, Kwesiga B, Bulage L, Kadobera D, Edward Okello P, Riolexus Ario A. Factors associated with acute watery diarrhea among children aged 0-59 months in Obongi District, Uganda, April 2022: A case-control study Preventive medicine reports 40:102666 2024 [PMID: 38435417]
  25. Bennis SL, Rohloff CT, Zhang Z, Kohli N, Zoschke IN, Rosser BRS, Nyitray AG, Wilkerson JM, Stull CL, Khariwala SS, Ross MW. Sexual Behavior and Perceived Risk for Oropharyngeal Cancer Among Men Who Have Sex With Men: A Psychometric Scale Validation Sexually transmitted diseases 51(4):289-294 2024 [PMID: 38430512]
  26. Alie MS, Abebe GF, Negesse Y, Gichew S. Prevalence and determinants to COVID-19 vaccine hesitancy among people living with HIV in Bench Sheko zone, Southwest Ethiopia: A multi-center study Heliyon 10(6):e27901 2024 [PMID: 38496901]
  27. Gunasingha RMKD, Herrick-Reynolds K, Sanford JA, Radowsky J. Iatrogenic immunodeficiency-associated lymphoproliferative disorder presenting as small bowel perforation BMJ case reports 17(3) 2024 [PMID: 38553024]
  28. Cassidy T, Stephenson KE, Barouch DH, Perelson AS. Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1 PLoS computational biology 20(3):e1011518 2024 [PMID: 38551976]
  29. Zurashvili T, Chakhaia T, King EJ, DeHovitz J, Djibuti M. HIV stigma and other barriers to COVID-19 vaccine uptake among Georgian people living with HIV/AIDS: A mixed-methods study PLOS global public health 4(3):e0003069 2024 [PMID: 38547297]
  30. Vechi HT, Bay MB, Freitas CHS, Sant'anna JGFC, Brites C, Lima KC. Factors associated with hepatitis A susceptibility among men who have sex with men using HIV pre-exposure prophylaxis in Northeastern Brazil: A cross-sectional study PloS one 19(3):e0301397 2024 [PMID: 38547222]
  31. Laban N, Bosomprah S, Chilengi R, Simuyandi M, Chisenga C, Ng'ombe H, Musukuma-Chifulo K, Goodier M. Human Cytomegalovirus Seropositivity and Its Influence on Oral Rotavirus Vaccine Immunogenicity: A Specific Concern for HIV-Exposed-Uninfected Infants Clinical and experimental immunology 2024 [PMID: 38546123]
  32. Bertumen JB, Pascopella L, Han E, Glenn-Finer R, Wong RJ, Chitnis A, Jaganath D, Jewell M, Gounder P, McElroy S, Stockman L, Barry P. Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 [PMID: 38531668]
  33. Ottaway Z, Campbell L, Fox J, Burns F, Hamzah L, Kegg S, Rosenvinge M, Schoeman S, Price D, Jones R, Miller RF, Tariq S, Post FA. HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in England HIV medicine 2024 [PMID: 38529684]
  34. Tenggara MK, Oh SH, Yang C, Nariya HK, Metz AM, Upadhyay AA, Gudipati DR, Guo L, McGhee EG, Gill K, Viox EG, Mason RD, Doria-Rose NA, Foulds KE, Mascola JR, Du Y, Fu H, Altman JD, Yan Q, Sheng Z, Bosinger SE, Kong R. Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolution Cell reports 43(3):113948 2024 [PMID: 38483908]
  35. Muzammil K, Hooshiar MH, Varmazyar S, Omar TM, Karim MM, Aadi S, Kalavi S, Yasamineh S. Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection Microbial cell factories 23(1):90 2024 [PMID: 38528584]
  36. Zhang Y, Zhang M, Wu H, Wang X, Zheng H, Feng J, Wang J, Luo L, Xiao H, Qiao C, Li X, Zheng Y, Huang W, Wang Y, Wang Y, Shi Y, Feng J, Chen G. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus eLife 12 2024 [PMID: 38526940]
  37. Quigley J, Hussain T, Arthur C. False-positive HIV screening test in a healthcare student Occupational medicine (Oxford, England) 2024 [PMID: 38526854]
  38. Gianella S, Anderson C, Chaillon A, Wells A, Porrachia M, Caballero G, Vargas M, Lonergan J, Woodworth B, Gaitan N, Rawlings SA, Muttera L, Harkness L, Little SJ, May S, Smith D. Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy AIDS (London, England) 2024 [PMID: 38526550]
  39. Spencer JC, Spees LP, Biddell CB, Odebunmi OO, Ilyasova AA, Yanguela J, Lich KH, Mills SD, Higgins CR, Ozawa S, Wheeler SB. Inclusion of marginalized populations in HPV vaccine modeling: A systematic review Preventive medicine 182:107941 2024 [PMID: 38522627]
  40. Coussens AK, Zaidi SMA, Allwood BW, Dewan PK, Gray G, Kohli M, Kredo T, Marais BJ, Marks GB, Martinez L, Ruhwald M, Scriba TJ, Seddon JA, Tisile P, Warner DF, Wilkinson RJ, Esmail H, Houben RMGJ. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise The Lancet. Respiratory medicine 2024 [PMID: 38527485]
  41. Reeves DB, Mayer BT, deCamp AC, Huang Y, Zhang B, Carpp LN, Magaret CA, Juraska M, Gilbert PB, Montefiori DC, Bar KJ, Cardozo-Ojeda EF, Schiffer JT, Rossenkhan R, Edlefsen P, Morris L, Mkhize NN, Williamson C, Mullins JI, Seaton KE, Tomaras GD, Andrew P, Mgodi N, Ledgerwood JE, Cohen MS, Corey L, Naidoo L, Orrell C, Goepfert PA, Casapia M, Sobieszczyk ME, Karuna ST, Edupuganti S. Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials Nature communications 15(1):2575 2024 [PMID: 38519455]
  42. Owusu M, Adu E, Kalu LE, Martey E, Acheampong G, Enimil A, Appiah JA, Badu-Peprah A, Sylverken J, Sylverken AA, Nguah SB, Westeel E, Pouzol S, Drosten C, Adu-Sarkodie Y. Aetiological agents of pneumonia among HIV and non-HIV infected children in Ghana: A case-control study PloS one 19(3):e0299222 2024 [PMID: 38517865]
  43. Ladhani SN, White PJ, Campbell H, Mandal S, Borrow R, Andrews N, Bhopal S, Saunders J, Mohammed H, Drisdale-Gordon L, Callan E, Sinka K, Folkard K, Fifer H, Ramsay ME. Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK The Lancet. Infectious diseases 2024 [PMID: 38521080]
  44. Hentzien M, Bonnet F, Bernasconi E, Biver E, Braun DL, Munting A, Leuzinger K, Leleux O, Musardo S, Prendki V, Schmid P, Staehelin C, Stoeckle M, Walti CS, Wittkop L, Appay V, Didierlaurent AM, Calmy A. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol BMC infectious diseases 24(1):329 2024 [PMID: 38504173]
  45. Moodie Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, Omar FL, Kee JJ, Bekker LG, Laher F, Naicker N, Jani I, Mgodi NM, Hunidzarira P, Sebe M, Miner MD, Polakowski L, Ramirez S, Nebergall M, Takuva S, Sikhosana L, Heptinstall J, Seaton KE, De Rosa S, Diazgranados CA, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, Tomaras GD, McElrath MJ, Corey L, Mngadi K, Goepfert P. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial PLoS medicine 21(3):e1004360 2024 [PMID: 38502656]
  46. Marinda E, Mathentamo Q, Coulson N, Parker S, Dmc Katoto P, Houston G, Magampa M, Pillay N, Ngungu M, Wiysonge CS, van Rooyen H. Impact evaluation of a youth led intervention to increase COVID-19 vaccine uptake in Kwazulu-Natal, South Africa Vaccine 42(8):2089-2098 2024 [PMID: 38423816]
  47. Sop J, Traut CC, Dykema AG, Hunt JH, Beckey TP, Basseth CR, Antar AAR, Laeyendecker O, Smith KN, Blankson JN. Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4(+) T cell clonotypes Cell reports. Medicine 5(3):101442 2024 [PMID: 38423018]
  48. Xu MA, Choi J, Rosenberger JG, Zimmerman RS, DiClemente R. Determinants of an HIV Preventive Vaccine among a Highly Vulnerable Population: African American Men Who Have Sex with Men Vaccines 12(3) 2024 [PMID: 38543957]
  49. Li X, Kou Z, Liu T, An W, An W, Zhang W, Zhang K, Dong J, Yu J, Li Y, Zhao C. Exploratory Study of the Phase IV Immunization Schedule of Quadrivalent Influenza Split-Virion Vaccine in Children Aged 3-8 Years Vaccines 12(3) 2024 [PMID: 38543956]
  50. Ghorai S, Shand H, Patra S, Panda K, Santiago MJ, Rahman MS, Chinnapaiyan S, Unwalla HJ. Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems Pharmaceutics 16(3) 2024 [PMID: 38543301]
  51. Smith S, Beima-Sofie K, Naveed A, Bhatia N, Micheni M, Nguyen AT, Slaughter F, Wang L, Prabhu S, Wallace S, Simoni J, Graham SM. Impact of the COVID-19 Pandemic on Persons Living with HIV in Western Washington: Examining Lived Experiences of Social Distancing Stress, Personal Buffers, and Mental Health AIDS and behavior 2024 [PMID: 38493281]
  52. Ishengoma DS, Mandara CI, Madebe RA, Warsame M, Ngasala B, Kabanywanyi AM, Mahende MK, Kamugisha E, Kavishe RA, Muro F, Mandike R, Mkude S, Chacky F, Njau R, Martin T, Mohamed A, Bailey JA, Fola AA. Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania Malaria journal 23(1):79 2024 [PMID: 38491359]
  53. Karim F, Riou C, Bernstein M, Jule Z, Lustig G, van Graan S, Keeton RS, Upton JL, Ganga Y, Khan K, Reedoy K, Mazibuko M, Govender K, Thambu K, Ngcobo N, Venter E, Makhado Z, Hanekom W, von Gottberg A, Hoque M, Karim QA, Abdool Karim SS, Manickchund N, Magula N, Gosnell BI, Lessells RJ, Moore PL, Burgers WA, de Oliveira T, Moosa MS, Sigal A. Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation Nature communications 15(1):2360 2024 [PMID: 38491050]
  54. Yin Y, Guo Y, Jiang Y, Quinlan B, Peng H, Crynen G, He W, Zhang L, Ou T, Bailey CC, Farzan M. In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies Nature biomedical engineering 2024 [PMID: 38486104]
  55. Maciel M Jr, Amara RR, Bar KJ, Crotty S, Deeks SG, Duplessis C, Gaiha G, McElrath MJ, McMichael A, Palin A, Rutishauser R, Shapiro S, Smiley ST, D'Souza MP. Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report NPJ vaccines 9(1):61 2024 [PMID: 38485736]
  56. Kim JH, Tack B, Fiorino F, Pettini E, Marchello C, Jacobs J, Crump J, Marks F. Examining geospatial and temporal distribution of invasive non-typhoidal Salmonella disease occurrence in sub-Saharan Africa: a systematic review and modelling study BMJ open 14(3):e080501 2024 [PMID: 38485477]
  57. Müller NF, Bouckaert RR, Wu CH, Bedford T. MASCOT-Skyline integrates population and migration dynamics to enhance phylogeographic reconstructions bioRxiv : the preprint server for biology 2024 [PMID: 38496513]
  58. Choi MW, Isidoro CA, Gillgrass A. Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection Current opinion in virology 66:101398 2024 [PMID: 38484474]
  59. Iseselo MK, Tarimo EAM. Comprehension of informed consent and voluntary participation in registration cohorts for phase IIb HIV vaccine trial in Dar Es Salaam, Tanzania: a qualitative descriptive study BMC medical ethics 25(1):29 2024 [PMID: 38481301]
  60. Grüner E, Grossegesse M, Stern D, Ober V, Eser TM, Reiling G, Stirner R, Ibarra G, Postel N, Conca R, Dächert C, Grifoni A, Sette A, Bogner J, Seybold U, Roider J. Mpox-specific immune responses elicited by vaccination or infection in people living with HIV The Journal of infectious diseases 2024 [PMID: 38478746]
  61. Tarrés-Freixas F, Clotet B, Carrillo J, Blanco J. Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention Vaccines 12(3) 2024 [PMID: 38543932]
  62. Dain AS, Diorio C, Fisher BT, Hankins JS, Witmer CM, Boustany M, Burton M, Ferrolino J, Sadaf S, Ross HS, Maron G. Description of a national, multi-center registry of patients with sickle cell disease and SARS-CoV-2 infection: Data from the Pediatric COVID-19 United States Registry Pediatric blood & cancer :e30909 2024 [PMID: 38469996]
  63. Avallone F, Hickson F. Sexual Health Needs Among Men Who Engage in Transactional Sex with Men in the UK Archives of sexual behavior 2024 [PMID: 38467959]
  64. deCamp AC, Corcoran MM, Fulp WJ, Willis JR, Cottrell CA, Bader DLV, Kalyuzhniy O, Leggat DJ, Cohen KW, Hyrien O, Menis S, Finak G, Ballweber-Fleming L, Srikanth A, Plyler JR, Rahaman F, Lombardo A, Philiponis V, Whaley RE, Seese A, Brand J, Ruppel AM, Hoyland W, Mahoney CR, Cagigi A, Taylor A, Brown DM, Ambrozak DR, Sincomb T, Mullen TM, Maenza J, Kolokythas O, Khati N, Bethony J, Roederer M, Diemert D, Koup RA, Laufer DS, McElrath JM, McDermott AB, Karlsson Hedestam GB, Schief WR. Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming NPJ vaccines 9(1):58 2024 [PMID: 38467663]
  65. Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, McCallum M, Bowen JE, Veesler D, Sadoff J, Gray GE, Roels S, Vandebosch A, Stieh DJ, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert PA, de Sousa LP, Silva MST, Casapia M, Losso MH, Little SJ, Gaur A, Bekker LG, Garrett N, Truyers C, Van Dromme I, Swann E, Marovich MA, Follmann D, Neuzil KM, Corey L, Greninger AL, Roychoudhury P, Hyrien O, Gilbert PB. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features Nature communications 15(1):2175 2024 [PMID: 38467646]
  66. Gallagher KE, Awori JO, Knoll MD, Rhodes J, Higdon MM, Hammitt LL, Prosperi C, Baggett HC, Brooks WA, Fancourt N, Feikin DR, Howie SRC, Kotloff KL, Tapia MD, Levine OS, Madhi SA, Murdoch DR, O'Brien KL, Thea DM, Baillie VL, Ebruke BE, Kamau A, Moore DP, Mwananyanda L, Olutunde EO, Seidenberg P, Sow SO, Thamthitiwat S, Scott JAG. Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management PloS one 19(3):e0297159 2024 [PMID: 38466696]
  67. Galati L, Chiantore MV, Marinaro M, Di Bonito P. Human Oncogenic Viruses: Characteristics and Prevention Strategies-Lessons Learned from Human Papillomaviruses Viruses 16(3) 2024 [PMID: 38543781]
  68. . Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Lancet (London, England) 2024 [PMID: 38484753]
  69. Aung PP, Han KT, Groot W, Biesma R, Thein ZW, Htay T, Lin Z, Aye KH, Adams M, Pavlova M. Heterogeneity in the prevalence of subclinical malaria, other co-infections and anemia among pregnant women in rural areas of Myanmar: a community-based longitudinal study Tropical medicine and health 52(1):22 2024 [PMID: 38459581]
  70. Al-Talib M, Dimonte S, Humphreys IR. Mucosal T-cell responses to chronic viral infections: Implications for vaccine design Cellular & molecular immunology 2024 [PMID: 38459243]
  71. Cohen J. Skin side effects stymie advance of HIV vaccine Science (New York, N.Y.) 383(6687):1044 2024 [PMID: 38452071]
  72. Olvera A, Romero-Martin L, Oriol-Tordera B, Rosas-Umbert M, Escribà T, Mothe B, Brander C. Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses Vaccines 12(3) 2024 [PMID: 38543913]
  73. Mayman Y, Crowley T, van Wyk B. Health Workers' Responses to COVID-19 Pandemic's Impact on Service Delivery to Adolescents in HIV Treatment in Cape Town, South Africa: A Qualitative Study Healthcare (Basel, Switzerland) 12(6) 2024 [PMID: 38540573]
  74. Diana P, Esposito S. Epidemiology, risk factors, and prevention strategies of HIV, HPV, and other sexually transmitted infections among cisgender and transgender youth: a narrative review Frontiers in public health 12:1342532 2024 [PMID: 38515602]
  75. Colón W, Oriol Mathieu V, Hural J, Hattingh L, Adungo F, Lagatie O, Lavreys L, Allen M, Anzala O, Espy N, Fransen K, Garcia PJ, Maciel M Jr, Murtagh M, Peel SA, Peeling RW, Tan LLJ, Warren M, Pau MG, D'Souza PM. HIV Diagnostics and Vaccines: It Takes Two to Tango The Journal of infectious diseases 2024 [PMID: 38451247]
  76. Hershfield M, Tarrant T. Adenosine Deaminase Deficiency 1993 [PMID: 20301656]
  77. Kumar S, Dasgupta S, Sajadi MM, Snyder GA, DeVico AL, Ray K. Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins Viruses 16(3) 2024 [PMID: 38543772]
  78. Ninyio N, Schmitt K, Sergon G, Nilsson C, Andersson S, Scherbak N. Correction: Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9 Microbial cell factories 23(1):75 2024 [PMID: 38448924]
  79. Altinawe J, Akkawi ME, Kharrat Helu N, Hassan Q, Nattouf AH. Seroprevalence and risk factors of HBV, HCV and HIV among hemodialysis patients: a multicenter cross-sectional study from Damascus Syria BMC infectious diseases 24(1):289 2024 [PMID: 38448805]
  80. SeyedAlinaghi S, Afsahi AM, Mirzapour P, Afzalian A, Shahidi R, Dashti M, Ghasemzadeh A, Paranjkhoo P, Parsaei Z, Pashaei A, Mohammadi P, Najafi MS, Mahrokhi S, Matini P, Moradi A, Karimi A, Afroughi S, Mehraeen E, Dadras O. Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence Infectious disorders drug targets 2024 [PMID: 38445691]
  81. Sanchez S, Dangi T, Awakoaiye B, Irani N, Fourati S, Richner J, Penaloza-MacMaster P. Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation bioRxiv : the preprint server for biology 2024 [PMID: 38496467]
  82. Wijesekera A, Weeramange CE, Vasani S, Kenny L, Knowland E, Seneviratne J, Punyadeera C. Surveillance of human papillomavirus through salivary diagnostics - A roadmap to early detection of oropharyngeal cancer men Tumour virus research 17:200278 2024 [PMID: 38442788]
  83. Fursa O, Bannister W, Neesgaard B, Podlekareva D, Kowalska J, Benfield T, Gerstoft J, Reekie J, Rasmussen LD, Aho I, Guaraldi G, Staub T, Miro JM, Laporte JM, Elbirt D, Trofimova T, Sedlacek D, Matulionyte R, Oprea C, Bernasconi E, Hadžiosmanović V, Mocroft A, Peters L. SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort HIV medicine 2024 [PMID: 38433476]
  84. Thorpe J, Sawaengdee W, Ward D, Campos M, Wichukchinda N, Chaiyasirinroje B, Thanraka A, Chumpol J, Phelan JE, Campino S, Mahasirimongkol S, Clark TG. Multi-platform whole genome sequencing for tuberculosis clinical and surveillance applications Scientific reports 14(1):5201 2024 [PMID: 38431684]
  85. Faraone JN, Wang X, Qu P, Zheng YM, Vincent E, Xu H, Liu SL. Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination Journal of medical virology 96(3):e29520 2024 [PMID: 38528837]
  86. Pampati S, Liddon N, Stuart EA, Waller LA, Mpofu JJ, Lopman B, Adkins SH, Guest JL, Jones J. Disparities in Unmet Health Care Needs Among US Children During the COVID-19 Pandemic Annals of family medicine 22(2):130-139 2024 [PMID: 38527826]
  87. Ramírez-Olivencia G, Velasco Arribas M, Vera García MM, Casabona J, Martínez MJ, Membrillo De Novales FJ. Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study) Open forum infectious diseases 11(3):ofae105 2024 [PMID: 38524223]
  88. Baltes V, de Boissieu P, Champenois K, Luan L, Seng R, Essat A, Novelli S, Spire B, Molina JM, Goujard C, Meyer L. Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study Journal of the International AIDS Society 27(3):e26226 2024 [PMID: 38462760]
  89. Nerlander L, Champezou L, Gomes Dias J, Aspelund G, Berlot L, Constantinou E, Díaz A, Epštein J, Fogarassy E, Hernando V, Hoffmann P, Igoe D, Klavs I, Pinto Leite P, Liitsola K, McIntyre A, Molnár Z, Olsen AO, Pires-Afonso Y, Putniņa R, Rudaitis K, Siakallis G, de Stoppelaar S, Suligoi B, Hannila-Handelberg T, Velicko I, Cabral Veríssimo V, Visser M, Wessman M, Mårdh O. Sharp increase in gonorrhoea notifications among young people, EU/EEA, July 2022 to June 2023 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 29(10) 2024 [PMID: 38456219]
  90. Karmarkar EN, Golden MR, Kerani RP, Pogosjans S, Chow EJ, Bender Ignacio RA, Ramchandani MS, Kay MK, Cannon CA, Dombrowski JC. Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study-King County, Washington, May-October 2022 Open forum infectious diseases 11(3):ofae029 2024 [PMID: 38456195]
  91. Choi CI, Lee SJ, Choi JB, Kim TH, Lee JW, Kim JM, Bae S. 2023 Korean sexually transmitted infections guidelines by the Korean Association of Urogenital Tract Infection and Inflammation: Human papillomavirus vaccination Investigative and clinical urology 65(2):108-114 2024 [PMID: 38454819]
  92. Kajiita RM, Kang'ethe SM. The Pandemics of Mass Destruction: A Comparative Analysis of HIV/AIDS and Coronavirus (COVID-19) Journal of multidisciplinary healthcare 17:889-899 2024 [PMID: 38445068]
  93. Liu AY, Gundacker H, Richardson B, Chen BA, Hoesley C, van der Straten A, Brown A, Beamer M, Robinson J, Jacobson CE, Scheckter R, Bunge K, Schwartz J, Thurman A, Piper JM, Marzinke MA. Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States Journal of the International AIDS Society 27(3):e26223 2024 [PMID: 38444118]
  94. Mohareb AM, Kouamé MG, Nouaman M, Kim AY, Larmarange J, Neilan AM, Lacombe K, Freedberg KA, Boyd A, Coffie P, Hyle EP. What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic? Journal of the International AIDS Society 27(3):e26218 2024 [PMID: 38444112]
  95. Haaland RE, Fountain J, Edwards TE, Dinh C, Martin A, Omoyege D, Conway-Washington C, Kelley CF, Heneine W. Pharmacokinetics of single dose doxycycline in the rectum, vagina, and urethra: implications for prevention of bacterial sexually transmitted infections EBioMedicine 101:105037 2024 [PMID: 38428259]
  96. Majumder M, Pal S, Kumar Tiwari P. Vaccination impact on impending HIV-COVID-19 dual epidemic with autogenous behavior modification: Hill-type functional response and premeditated optimization technique Chaos (Woodbury, N.Y.) 34(3) 2024 [PMID: 38427935]
  97. Aber JO, Bongomin F, Opio SL, Ochola E. Hepatitis B vaccine uptake and associated factors among adults of Gulu city in Northern Uganda: A community-based cross-sectional study PloS one 19(3):e0297617 2024 [PMID: 38427654]
  98. Almomani O, Nnamutete J, Shao Z, Biribawa VM, Ssemunywa H, Namuniina A, Okech B, Ulanova S, Zuanazzi D, Liu CM, Tobian AAR, Galiwango RM, Kaul R, Prodger JL. Effect of cryopreservation on CD4+ T cell subsets in foreskin tissue PloS one 19(3):e0297884 2024 [PMID: 38427640]
  99. Muecksch F, Fackler OT. Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine Signal transduction and targeted therapy 9(1):49 2024 [PMID: 38424414]
  100. Zuo K, Gao W, Wu Z, Zhang L, Wang J, Yuan X, Li C, Xiang Q, Lu L, Liu H. Evolution of Virology: Science History through Milestones and Technological Advancements Viruses 16(3) 2024 [PMID: 38543740]
  101. Kaur A, Vaccari M. Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects Viruses 16(3) 2024 [PMID: 38543734]
  102. Alie MS, Abebe GF, Negesse Y, Girma D, Adugna A. Pandemic fatigue, behavioral intention and predictors of COVID-19 vaccination among individuals living with HIV in Bench Sheko Zone, in Southern Ethiopia, application of TBP: a facility based cross sectional study Frontiers in public health 12:1305777 2024 [PMID: 38476495]
  103. Liu WD, Lin MS, Sun HY, Shih MC, Chuang YC, Huang YS, Lin KY, Li GC, Wu PY, Chen LY, Liu WC, Su YC, He PC, Chen YT, Lin CY, Cheng YC, Yao Y, Yeh YC, Liu CC, Pan MY, Luo YZ, Chang HY, Wang JT, Sheng WH, Hsieh SM, Chang SY, Hung CC. Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2024 [PMID: 38429206]
  104. Gogoi M, Martin CA, Bird PW, Wiselka MJ, Gardener J, Ellis K, Renals V, Lewszuk AJ, Hargreaves S, Pareek M. Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis Journal of migration and health 9:100217 2024 [PMID: 38455071]
  105. Gentile D, Chiummiento L, Santarsiere A, Funicello M, Lupattelli P, Rescifina A, Venuti A, Piperno A, Sciortino MT, Pennisi R. Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2 Viruses 16(3) 2024 [PMID: 38543704]
  106. Lagadinou M, Spiliopoulou K, Paraskevas T, Gkentzi D, Assimakopoulos S, Katsakiori P, Leonidou L, Marangos M. Knowledge and Attitudes of Medical and Nursing Students in a Greek University Regarding Sexually Transmitted Diseases International journal of environmental research and public health 21(3) 2024 [PMID: 38541253]
  107. Szabó D, Crowe A, Mamotte C, Strappe P. Natural products as a source of Coronavirus entry inhibitors Frontiers in cellular and infection microbiology 14:1353971 2024 [PMID: 38449827]
  108. Heil M. Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies Frontiers in immunology 14:1259879 2023 [PMID: 38439942]
  109. Kumar S, Bajpai P, Joyce C, Kabra SK, Lodha R, Burton DR, Briney B, Luthra K. B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes Frontiers in immunology 15:1272493 2024 [PMID: 38433846]
  110. Runtuwene LR, Parbie PK, Mizutani T, Ishizaka A, Matsuoka S, Abana CZ, Kushitor D, Bonney EY, Ofori SB, Kiyono H, Ishikawa K, Ampofo WK, Matano T. Longitudinal analysis of microbiome composition in Ghanaians living with HIV-1 Frontiers in microbiology 15:1359402 2024 [PMID: 38426062]
  111. Van Zyl GU, Maponga T, Rabie H, Taljaard J. The role of new hepatitis B vaccines in South Africa South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 114(2):e1473 2024 [PMID: 38525577]
  112. Castello-Branco Ribeiro L, Paixão F, Costa F, Correia P. Migrant Pathology Screening in the Pediatric Population: A Five-Year Retrospective Study From a Level II Hospital Cureus 16(2):e53770 2024 [PMID: 38465108]
  113. Balakrishnan P, Sathish S, Saravanan S. HIV-Encoded Gene Therapy as Anti-cancer Therapeutics: A Narrative Review Cureus 16(2):e53431 2024 [PMID: 38435173]
  114. Yasri S, Wiwanitkit V. Expected usefulness of the third dose of COVID-19 vaccine for adolescents living with underlying HIV infection Indian journal of pharmacology 56(1):68-70 2024 [PMID: 38454595]
  115. Stanley CC, Zulu M, Msuku H, Phiri VS, Kazembe LN, Chinkhumba J, Mvalo T, Mathanga DP. Competing risks modeling of length of hospital stay enhances risk-stratification of patient care: application to under-five children hospitalized in Malawi Frontiers in epidemiology 3:1274776 2023 [PMID: 38455913]
  116. Kwedi Nolna S, Niba M, Djadda C, Masumbe Netongo P. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in HIV-positive and HIV-negative patients in clinical settings in Douala, Cameroon Frontiers in epidemiology 3:1212220 2023 [PMID: 38455949]
  117. Dzomba A, Ginsburg C, Kabudula CW, Yorlets RR, Ndagurwa P, Harawa S, Lurie MN, McGarvey ST, Tollman S, Collinson MA, White MJ, Gomez-Olive FX. Epidemiology of chronic multimorbidity and temporary migration in a rural South African community in health transition: A cross-sectional population-based analysis Frontiers in epidemiology 3:1054108 2023 [PMID: 38455922]

Machupo virus

  1. Nunberg JH, Westover JB, York J, Jung KH, Bailey KW, Boardman KM, Li M, Furnell RS, Wasson SR, Murray JS, Kaundal R, Thomas AJ, Gowen BB. Restoration of virulence in the attenuated Candid#1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPC Journal of virology 98(4):e0011224 2024 [PMID: 38506509]

Marburg virus

  1. Abdel-Moneim AS, Murovska M, Söderlund-Venermo M, Vakharia VN, Wilson WC, Gladue DP, Moore MD, Alonso C, Abdelwahab SF, Venter M, Malik YS, Zhengli S, Saxena SK, Varma A, Kuhn RJ. WSV2023 - The second meeting of the world society for virology: One health - One world - One virology Virology 594:110049 2024 [PMID: 38527382]
  2. Zhang Y, Zhang M, Wu H, Wang X, Zheng H, Feng J, Wang J, Luo L, Xiao H, Qiao C, Li X, Zheng Y, Huang W, Wang Y, Wang Y, Shi Y, Feng J, Chen G. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus eLife 12 2024 [PMID: 38526940]
  3. Harris PE, Burkholz S, Herst CV, Rubsamen RM. Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine Vaccines 12(3) 2024 [PMID: 38543955]
  4. Limburg H, Schwerdtner M, Wilson E, Roth B, Cassart JP, Werner AD, Harbig A, Böttcher-Friebertshäuser E, Stokes A. pH inactivation of SARS-CoV-2 and SARS-CoV in virus spiked protein A eluates from a mAb purification process Biologicals : journal of the International Association of Biological Standardization 86:101753 2024 [PMID: 38492418]
  5. Mitu RA, Islam MR. The Current Pathogenicity and Potential Risk Evaluation of Marburg Virus to Cause Mysterious "Disease X"-An Update on Recent Evidences Environmental health insights 18:11786302241235809 2024 [PMID: 38440221]

Mycobacterium tuberculosis (tuberculosis)

  1. Santos CS, Chen JP, Nikiphorou E, Tseng CW, Gutiérrez CET, Tan AL, Nune A, Kadam E, Kuwana M, Day J, Saha S, Velikova T, Lilleker JB, Caballero-Uribe CV, Sen P, Chinoy H, Aggarwal R, Agarwal V, Gupta L, Chen YM. Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study Rheumatology international 44(5):805-817 2024 [PMID: 38470502]
  2. Wood RC, Luabeya AK, Dragovich RB, Olson AM, Lochner KA, Weigel KM, Codsi R, Mulenga H, de Vos M, Kohli M, Penn-Nicholson A, Hatherill M, Cangelosi GA. Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB Ultima Journal of clinical microbiology 62(4):e0001924 2024 [PMID: 38483169]
  3. Gupta A, Thirunavukkarasu S, Rangel-Moreno J, Ahmed M, Swanson RV, Mbandi SK, Smrcka AV, Kaushal D, Scriba TJ, Khader SA. Phospholipase C epsilon-1 (PLCƐ1) mediates macrophage activation and protection against tuberculosis Infection and immunity 92(4):e0049523 2024 [PMID: 38451080]
  4. Palekyte A, Morkowska A, Billington O, Morris-Jones S, Millard J, Marakalala MJ, Owolabi O, Sambou B, Zumla A, Sutherland JS, McHugh TD, Honeyborne I. Acetic Acid Enables Molecular Enumeration of Mycobacterium tuberculosis from Sputum and Eliminates the Need for a Biosafety Level 3 Laboratory Clinical chemistry 70(4):642-652 2024 [PMID: 38479728]
  5. Deng LJ, Ye Q, Luo SY, Wang QX, Fang S. Case Report: Clinical and Pathological Findings of Tuberculous Gumma: A Case Report and Literature Review The American journal of tropical medicine and hygiene 110(4):805-808 2024 [PMID: 38471180]
  6. Meng L, Harris L, Shaw L, Lymon H, Reses H, Bell J, Lu PJ, Gibbs-Scharf L, Chorba T. Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged ≥ 12 years, United States, August 2021-October 2022 Vaccine 42(9):2122-2126 2024 [PMID: 38453621]
  7. Kazi F, Mushtaq A. Alemnew Dagnew-developing a new TB vaccine The Lancet. Infectious diseases 24(4):348 2024 [PMID: 38519258]
  8. To KW, Zhang R, Lee SS. Is the new tuberculous antigen-based skin test ready for use as an alternative to tuberculin skin test/interferon-gamma release assay for tuberculous diagnosis? A narrative review International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 141S:106992 2024 [PMID: 38458426]
  9. Goletti D, Al-Abri S, Migliori GB, Arlehamn CL, Haldar P, Sundling C, da Costa C, To KW, Martineau AR, Petersen E, Zumla A, Shan Lee S. World Tuberculosis Day 2024 theme "Yes! We can end TB" can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 141S:106993 2024 [PMID: 38458422]
  10. Brinkmann F, Friedrichs A, Behrens GM, Behrens P, Berner R, Caliebe A, Denkinger CM, Giesbrecht K, Gussew A, Hoffmann AT, Hojenski L, Hovardovska O, Dopfer-Jablonka A, Kaasch AJ, Kobbe R, Kraus M, Lindner A, Maier C, Mitrov L, Nauck M, de Miranda SN, Scherer M, Schmiedel Y, Stahl D, Timmesfeld N, Toepfner N, Vehreschild J, Wohlgemuth WA, Petersmann A, Vehreschild MJGT. Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM) Journal of infection and public health 17(4):642-649 2024 [PMID: 38458134]
  11. Rudeeaneksin J, Bunchoo S, Phetsuksiri B, Srisungngam S, Khummin R, Thapa J, Nakajima C, Suzuki Y. The first insight into Mycobacterium tuberculosis complex isolates in the lower northern region in Thailand Transactions of the Royal Society of Tropical Medicine and Hygiene 2024 [PMID: 38554067]
  12. Shi L, Gu R, Long J, Duan G, Yang H. Application of CRISPR-cas-based technology for the identification of tuberculosis, drug discovery and vaccine development Molecular biology reports 51(1):466 2024 [PMID: 38551745]
  13. Chlabicz M, Nabożny A, Koszelew J, Łaguna W, Szpakowicz A, Sowa P, Budny W, Guziejko K, Róg-Makal M, Pancewicz S, Kondrusik M, Czupryna P, Cudowska B, Lebensztejn D, Moniuszko-Malinowska A, Wierzbicki A, Kamiński KA. Medical Misinformation in Polish on the World Wide Web During the COVID-19 Pandemic Period: Infodemiology Study Journal of medical Internet research 26:e48130 2024 [PMID: 38551638]
  14. Michel AL. Vaccines to control tuberculosis in cattle Science (New York, N.Y.) 383(6690):1410-1411 2024 [PMID: 38547294]
  15. Fromsa A, Willgert K, Srinivasan S, Mekonnen G, Bedada W, Gumi B, Lakew M, Tadesse B, Bayissa B, Sirak A, Girma Abdela M, Gebre S, Chibssa T, Veerasami M, Vordermeier HM, Bakker D, Berg S, Ameni G, Juleff N, de Jong MCM, Wood J, Conlan A, Kapur V. BCG vaccination reduces bovine tuberculosis transmission, improving prospects for elimination Science (New York, N.Y.) 383(6690):eadl3962 2024 [PMID: 38547287]
  16. Niu H, Bai C, Zhu B, Zhang Y. Rapamycin improves the long-term T-cell memory and protective efficacy of tuberculosis subunit vaccine Microbial pathogenesis 190:106631 2024 [PMID: 38537761]
  17. Casais R, Iglesias N, Sevilla IA, Garrido JM, Balseiro A, Dominguez M, Juste RA. Non-specific effects of inactivated Mycobacterium bovis oral and parenteral treatment in a rabbit scabies model Veterinary research 55(1):41 2024 [PMID: 38532491]
  18. Bertumen JB, Pascopella L, Han E, Glenn-Finer R, Wong RJ, Chitnis A, Jaganath D, Jewell M, Gounder P, McElroy S, Stockman L, Barry P. Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 [PMID: 38531668]
  19. Burki T. Pivotal tuberculosis vaccine trial begins Lancet (London, England) 403(10432):1125 2024 [PMID: 38522438]
  20. Coussens AK, Zaidi SMA, Allwood BW, Dewan PK, Gray G, Kohli M, Kredo T, Marais BJ, Marks GB, Martinez L, Ruhwald M, Scriba TJ, Seddon JA, Tisile P, Warner DF, Wilkinson RJ, Esmail H, Houben RMGJ. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise The Lancet. Respiratory medicine 2024 [PMID: 38527485]
  21. Dashti F, Raisi A, Pourali G, Razavi ZS, Ravaei F, Sadri Nahand J, Kourkinejad-Gharaei F, Mirazimi SMA, Zamani J, Tarrahimofrad H, Hashemian SMR, Mirzaei H. A computational approach to design a multiepitope vaccine against H5N1 virus Virology journal 21(1):67 2024 [PMID: 38509569]
  22. Jackson S, Kabir Z, Comiskey C. Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011-2021 Vaccine 42(8):2099-2105 2024 [PMID: 38423810]
  23. Kaushik M, Shah VM, Murugesan S, Mani KK, Vardharajan S. Clinical profile and challenges faced in the management of optic neuritis: the Indian scenario International ophthalmology 44(1):138 2024 [PMID: 38488890]
  24. Shinde GP, Sutar Y, Kasdekar N, Joshi P, Rasool O, Ignatowicz L, Hamasur B, Hotha S. Synthesis of an Immunologically Active Heptamannoside of Mycobacterium tuberculosis by the [Au]/[Ag]-Catalyzed Activation of Ethynylcyclohexyl Glycosyl Carbonate Donor Organic letters 26(10):2034-2038 2024 [PMID: 38486497]
  25. Zeng L, Ma X, Qu M, Tang M, Li H, Lei C, Ji J, Li H. Immunogenicity and protective efficacy of Ag85A and truncation of PstS1 fusion protein vaccines against tuberculosis Heliyon 10(5):e27034 2024 [PMID: 38463854]
  26. Voogd L, Drittij AMHF, Dingenouts CKE, Franken KLMC, Unen VV, van Meijgaarden KE, Ruibal P, Hagedoorn RS, Leitner JA, Steinberger P, Heemskerk MHM, Davis MM, Scriba TJ, Ottenhoff THM, Joosten SA. Mtb HLA-E-tetramer-sorted CD8(+) T cells have a diverse TCR repertoire iScience 27(3):109233 2024 [PMID: 38439958]
  27. Ren H, He J, Dong J, Jiang G, Hao J, Han L. Tumor Immune Infiltration and Clinical Impact of Specific BCG-Related Genes in Melanoma Journal of leukocyte biology 2024 [PMID: 38478636]
  28. Doležalová K, Mališková B, Honegerová M, Hromádková M, Wallenfels J. TB index case tracing in the Roma community in the Czech Republic Epidemiology and infection 152:e45 2024 [PMID: 38465380]
  29. Mason PS, Holder T, Robinson N, Smith B, Hameed RT, Al Dulayymi JR, Hughes V, Stevenson K, Jones GJ, Vordermeier HM, Mc Kenna S, Baird MS. An ELISA Using Synthetic Mycolic Acid-Based Antigens with DIVA Potential for Diagnosing Johne's Disease in Cattle Animals : an open access journal from MDPI 14(6) 2024 [PMID: 38539946]
  30. Chugh S, Bahal RK, Dhiman R, Singh R. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development NPJ vaccines 9(1):57 2024 [PMID: 38461350]
  31. Kwon KW, Choi HG, Kim KS, Park SA, Kim HJ, Shin SJ. BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice NPJ vaccines 9(1):55 2024 [PMID: 38459038]
  32. Lin Z, Kaniraj JP, Holzheimer M, Nigou J, Gilleron M, Hekelaar J, Minnaard AJ. Asymmetric Total Synthesis and Structural Revision of DAT(2), an Antigenic Glycolipid from Mycobacterium tuberculosis Angewandte Chemie (International ed. in English) :e202318582 2024 [PMID: 38456226]
  33. Kurtz SL, Baker RE, Boehm FJ, Lehman CC, Mittereder LR, Khan H, Rossi AP, Gatti DM, Beamer G, Sassetti CM, Elkins KL. Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice PLoS pathogens 20(3):e1012069 2024 [PMID: 38452145]
  34. Ogongo P, Wassie L, Tran A, Columbus D, Sharling L, Ouma G, Ouma SG, Bobosha K, Lindestam Arlehamn CS, Gandhi NR, Auld SC, Rengarajan J, Day CL, Altman JD, Blumberg HM, Ernst JD. Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infection bioRxiv : the preprint server for biology 2024 [PMID: 38496518]
  35. Perez-Porcuna TM, Noguera-Julian A, Riera-Bosch MT, Macià-Rieradevall E, Santos-Santiago J, Rifà Pujol MÀ, Eril M, Aulet-Molist L, Padilla-Esteba E, Tórtola MT, Gómez I Prat J, Vilamala Bastarras A, Rebull-Fatsini JS, Papaleo A, Rius-Gordillo N, Gonçalves AQ, Naranjo-Orihuela À, Urgelles M, García-Lerín MG, Jimenez-Lladser G, Lorenzo-Pino B, Giuliano-Cuello MA, Pascual-Sánchez MT, Marco-García M, Abellana R, Espiau M, Altet-Gómez MN, Orcau-Palau A, Caylà JA, Soriano-Arandes A. Tuberculosis among children visiting friends & relatives Journal of travel medicine 2024 [PMID: 38438137]
  36. Thorpe J, Sawaengdee W, Ward D, Campos M, Wichukchinda N, Chaiyasirinroje B, Thanraka A, Chumpol J, Phelan JE, Campino S, Mahasirimongkol S, Clark TG. Multi-platform whole genome sequencing for tuberculosis clinical and surveillance applications Scientific reports 14(1):5201 2024 [PMID: 38431684]
  37. Eggenhuizen PJ, Ooi JD. The Influence of Cross-Reactive T Cells in COVID-19 Biomedicines 12(3) 2024 [PMID: 38540178]
  38. Dehghani A, Mamizadeh M, Karimi A, Hosseini SA, Siamian D, Shams M, Ghiabi S, Basati G, Abaszadeh A. Multi-epitope vaccine design against leishmaniasis using IFN-γ inducing epitopes from immunodominant gp46 and gp63 proteins Journal, genetic engineering & biotechnology 22(1):100355 2024 [PMID: 38494264]
  39. Momplaisir F, Rogo T, Alexander Parrish R, Delair S, Rigaud M, Caine V, Absalon J, Word B, Hewlett D. Ending Race-Conscious College Admissions and Its Potential Impact on the Infectious Disease Workforce Open forum infectious diseases 11(3):ofae083 2024 [PMID: 38444821]
  40. Krmeská V, Shen L, Nylén S, Wowk PF, Rothfuchs AG. BCG infection dose guides dendritic cell migration and T cell priming in the draining lymph node Scandinavian journal of immunology 99(3):e13342 2024 [PMID: 38441294]
  41. Lee S, Kim G, Park GM, Jeong J, Jung E, Lee BS, Jo E, Lee S, Yoon H, Jo KW, Kim SH, Lee J. Management of newborns and healthcare workers exposed to isoniazid-resistant congenital tuberculosis in the neonatal intensive care unit The Journal of hospital infection 147:40-46 2024 [PMID: 38432587]
  42. Nouri F, Shahrjerdi A, Zarnegarpour HA, Mosvari N. Diagnostic advancements: Isolating Mycobacterium avium ssp. paratuberculosis and unveiling its molecular identity with nested-PCR Cellular and molecular biology (Noisy-le-Grand, France) 70(2):18-23 2024 [PMID: 38430046]
  43. Specht AG, Ginese M, Kurtz SL, Elkins KL, Specht H, Beamer G. Host Genetic Background Influences BCG-Induced Antibodies Cross-Reactive to SARS-CoV-2 Spike Protein Vaccines 12(3) 2024 [PMID: 38543876]
  44. Godoy P, Martínez-Baz I, Parron I, García-Cenoz M, Ferras J, Carol M, Bes N, Guillaumes M, Godoy S, Toledo D, Follia N, Miret C, Pardos J, Alsedà M, Plans-Rubio P, Sanz I, Sala MR, Caylà JA, Mendioroz J, Muñoz-Almagro C, Castilla J, Domínguez Á, On Behalf Of The Sars-CoV-Transmission To Household Contacts Working Group. Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts: A Cohort Study Vaccines 12(3) 2024 [PMID: 38543874]
  45. Dos Santos PCP, Messina NL, de Oliveira RD, da Silva PV, Puga MAM, Dalcolmo M, Dos Santos G, de Lacerda MVG, Jardim BA, de Almeida E Val FF, Curtis N, Andrews JR, Croda J. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial The Lancet. Infectious diseases 2024 [PMID: 38423021]
  46. Dalvi A, Bargir UA, Natraj G, Shah I, Madkaikar M. Diagnosis and Management of Infections in Patients with Mendelian Susceptibility to Mycobacterial Disease Pathogens (Basel, Switzerland) 13(3) 2024 [PMID: 38535546]
  47. Tovar M, Sanz J, Moreno Y. Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China Frontiers in public health 12:1302688 2024 [PMID: 38463158]
  48. Alonso-Rodríguez N, Vianello E, van Veen S, Jenum S, Tonby K, van Riessen R, Lai X, Mortensen R, Ottenhoff THM, Dyrhol-Riise AM. Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy Frontiers in immunology 15:1350593 2024 [PMID: 38433842]
  49. Castello-Branco Ribeiro L, Paixão F, Costa F, Correia P. Migrant Pathology Screening in the Pediatric Population: A Five-Year Retrospective Study From a Level II Hospital Cureus 16(2):e53770 2024 [PMID: 38465108]
  50. Farokhnia A, Rampini SK, Gundelfinger M. [Complications of intravesical BCG therapy] Praxis 113(2):45-49 2024 [PMID: 38536193]
  51. Birner C, Hackenbroch C, Gagiannis D. Miliary Pneumonia as a Complication of BCG Instillation Deutsches Arzteblatt international 121(2):51 2024 [PMID: 38427941]
  52. Ivoylov AY, Polunin MM, Mileshina NA, Osipenkov SS, Radtsig AN. [Clinical case of tuberculous otitis media in early childhood] Vestnik otorinolaringologii 89(1):32-36 2024 [PMID: 38506023]
  53. Mishra HK. The Applications of ELISpot in the Identification and Treatment of Various Forms of Tuberculosis and in the Cancer Immunotherapies Methods in molecular biology (Clifton, N.J.) 2768:51-58 2024 [PMID: 38502387]

Nipah virus

  1. Pastor Y, Reynard O, Iampietro M, Surenaud M, Picard F, El Jahrani N, Lefebvre C, Hammoudi A, Dupaty L, Brisebard É, Reynard S, Moureaux É, Moroso M, Durand S, Gonzalez C, Amurri L, Gallouët AS, Marlin R, Baize S, Chevillard E, Raoul H, Hocini H, Centlivre M, Thiébaut R, Horvat B, Godot V, Lévy Y, Cardinaud S. A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease Cell reports. Medicine 5(3):101467 2024 [PMID: 38471503]
  2. Yang X, Xu K, Li S, Zhang J, Xie Y, Lou Y, Xiao X. Novel methods for the rapid and sensitive detection of Nipah virus based on a CRISPR/Cas12a system The Analyst 2024 [PMID: 38497408]

Plasmodium falciparum (Malaria)

  1. Jain A, Sharma R, Gautam L, Shrivastava P, Singh KK, Vyas SP. Biomolecular interactions between Plasmodium and human host: A basis of targeted antimalarial therapy Annales pharmaceutiques francaises 82(3):401-419 2024 [PMID: 38519002]
  2. Yu X, Min H, Yao S, Yao G, Zhang D, Zhang B, Chen M, Liu F, Cui L, Zheng L, Cao Y. Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine International immunopharmacology 131:111817 2024 [PMID: 38460299]
  3. Charital S, Shunmugam S, Dass S, Alazzi AM, Arnold C-S, Katris NJ, Duley S, Quansah NA, Pierrel F, Govin J, Yamaryo-Botté Y, Botté CY. The acyl-CoA synthetase TgACS1 allows neutral lipid metabolism and extracellular motility in Toxoplasma gondii through relocation via its peroxisomal targeting sequence (PTS) under low nutrient conditions mBio 15(4):e0042724 2024 [PMID: 38501871]
  4. Nelder MP, Schats R, Poinar HN, Cooke A, Brickley MB. Pathogen prospecting of museums: Reconstructing malaria epidemiology Proceedings of the National Academy of Sciences of the United States of America 121(15):e2310859121 2024 [PMID: 38527214]
  5. Dobbs KR, Atieli HE, Valim C, Beeson JG. Previous Malaria Exposures and Immune Dysregulation: Developing Strategies To Improve Malaria Vaccine Efficacy in Young Children The American journal of tropical medicine and hygiene 110(4):627-630 2024 [PMID: 38442424]
  6. Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares IS. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant Vaccine 42(9):2394-2406 2024 [PMID: 38448321]
  7. Zaman K, Schuind AE, Adjei S, Antony K, Aponte JJ, Buabeng PB, Qadri F, Kemp TJ, Hossain L, Pinto LA, Sukraw K, Bhat N, Agbenyega T. Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9-14 years of age: Interim analysis from a phase 3 clinical trial Vaccine 42(9):2290-2298 2024 [PMID: 38431444]
  8. Moita D, Prudêncio M. A new malaria vaccination tool based on replication-competent Plasmodium falciparum parasites EMBO molecular medicine 16(4):667-669 2024 [PMID: 38514792]
  9. Goswami D, Patel H, Betz W, Armstrong J, Camargo N, Patil A, Chakravarty S, Murphy SC, Sim BKL, Vaughan AM, Hoffman SL, Kappe SH. A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion EMBO molecular medicine 16(4):723-754 2024 [PMID: 38514791]
  10. . Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology 23(4):344-381 2024 [PMID: 38493795]
  11. Juniour Nsubuga E, Kirabo J, Kwiringira A, Andaku L, Magona Nerima S, Nsubuga F, Nakazzi R, Kwesiga B, Bulage L, Kadobera D, Edward Okello P, Riolexus Ario A. Factors associated with acute watery diarrhea among children aged 0-59 months in Obongi District, Uganda, April 2022: A case-control study Preventive medicine reports 40:102666 2024 [PMID: 38435417]
  12. Hill J, Bange T, Hoyt J, Kariuki S, Jalloh MF, Webster J, Okello G. Integration of the RTS,S/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective The Lancet. Global health 12(4):e672-e684 2024 [PMID: 38430916]
  13. Matson Z, Cooley G, Parameswaran N, Simon A, Bankamp B, Coughlin MM. shinyMBA: a novel R shiny application for quality control of the multiplex bead assay for serosurveillance studies Scientific reports 14(1):7442 2024 [PMID: 38548772]
  14. Doucoure M, Zeguime A, Niangaly A, Guindo MA, Doritchamou JYA, Assadou MH, Katile A, Kanoute MB, Perou S, Ouattara A, Sanogo S, Ouologuem B, Traore S, Dao B, Dembele D, Kone M, Kamate B, Sissoko K, Sankare S, Diarra S, Dolo A, Sissoko MS, Hume JCC, Cook D, Healy SA, Gorres JP, Traoré B, Gamiel J, Duffy PE, Sagara I. Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural Mali The American journal of tropical medicine and hygiene 2024 [PMID: 38531104]
  15. Indrihutami K, Chand K, Fahmia R, Rahardjani M, Wulandari F, Subekti D, Noviyanti R, Soebandrio A, Mallisa NT, Mardika IM, Budiman W, Suriswan I, Ertanto Y, Chen MC, Murshedkar T, Abebe Y, Sim BKL, Hoffman SL, Richie TL, Chen S, Elyazar IRF, Ekawati LL, Baird JK, Nelwan EJ. Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population The American journal of tropical medicine and hygiene 2024 [PMID: 38531102]
  16. Tenthani L, Seffren V, Kabaghe AN, Ogollah F, Soko M, Yadav R, Kayigamba F, Payne D, Wadonda-Kabondo N, Kampira E, Volkmann T, Sugandhi NS, Seydel K, Rogier E, Thwing JI, Gutman JR. SARS-CoV-2 Seroprevalence and Vaccine Uptake among Pregnant Women at First Antenatal Care Visits in Malawi The American journal of tropical medicine and hygiene 2024 [PMID: 38531097]
  17. Freville A, Stewart LB, Tetteh KKA, Treeck M, Cortes A, Voss TS, Tarr SJ, Baker DA, Conway DJ. Expression of the MSPDBL2 antigen in a discrete subset of Plasmodium falciparum schizonts is regulated by GDV1 but may not be linked to sexual commitment mBio :e0314023 2024 [PMID: 38530030]
  18. Dovizio M, Veronesi C, Bartolini F, Cavaliere A, Grego S, Pagliaro R, Procacci C, Ubertazzo L, Bertizzolo L, Muzii B, Parisi S, Perrone V, Baraldi E, Bozzola E, Mosca F, Esposti LD. Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy Italian journal of pediatrics 50(1):57 2024 [PMID: 38528616]
  19. Madhav H, Reddy GS, Rizvi Z, Jameel E, Patel TS, Rahman A, Yadav V, Fatima S, Heyat F, Pal K, Minju-Op A, Subbarao N, Bhattacharjee S, Dixit BC, Sijwali PS, Hoda N. Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of Plasmodial cysteine protease inhibitors for the treatment of malaria RSC medicinal chemistry 15(3):1022-1037 2024 [PMID: 38516592]
  20. Guo B, Borda V, Laboulaye R, Spring MD, Wojnarski M, Vesely BA, Silva JC, Waters NC, O'Connor TD, Takala-Harrison S. Strong positive selection biases identity-by-descent-based inferences of recent demography and population structure in Plasmodium falciparum Nature communications 15(1):2499 2024 [PMID: 38509066]
  21. Mertens JE. A History of Malaria and Conflict Parasitology research 123(3):165 2024 [PMID: 38504009]
  22. Venkatesan P. Routine malaria vaccinations start in Africa The Lancet. Microbe 2024 [PMID: 38513677]
  23. Allen T, Castellanos ME, Giacomin P, Karunaweera ND, Kupz A, Lol JC, Sharma D, Sikder S, Tedla B, van Eijk L, Vojisavljevic D, Zhao G, Pai S. Next-generation vaccines for tropical infectious diseases International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 143:107014 2024 [PMID: 38499058]
  24. Ishengoma DS, Mandara CI, Madebe RA, Warsame M, Ngasala B, Kabanywanyi AM, Mahende MK, Kamugisha E, Kavishe RA, Muro F, Mandike R, Mkude S, Chacky F, Njau R, Martin T, Mohamed A, Bailey JA, Fola AA. Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania Malaria journal 23(1):79 2024 [PMID: 38491359]
  25. Shanley HT, Taki AC, Byrne JJ, Nguyen N, Wells TNC, Jabbar A, Sleebs BE, Gasser RB. A phenotypic screen of the Global Health Priority Box identifies an insecticide with anthelmintic activity Parasites & vectors 17(1):131 2024 [PMID: 38486232]
  26. Kim JH, Tack B, Fiorino F, Pettini E, Marchello C, Jacobs J, Crump J, Marks F. Examining geospatial and temporal distribution of invasive non-typhoidal Salmonella disease occurrence in sub-Saharan Africa: a systematic review and modelling study BMJ open 14(3):e080501 2024 [PMID: 38485477]
  27. Amimo F. Malaria vaccination: hurdles to reach high-risk children BMC medicine 22(1):111 2024 [PMID: 38475775]
  28. Temizoz B, Shibahara T, Hioki K, Hayashi T, Kobiyama K, Lee MSJ, Surucu N, Sag E, Kumanogoh A, Yamamoto M, Gursel M, Ozen S, Kuroda E, Coban C, Ishii KJ. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation Frontiers in immunology 15:1353336 2024 [PMID: 38533502]
  29. Aung PP, Han KT, Groot W, Biesma R, Thein ZW, Htay T, Lin Z, Aye KH, Adams M, Pavlova M. Heterogeneity in the prevalence of subclinical malaria, other co-infections and anemia among pregnant women in rural areas of Myanmar: a community-based longitudinal study Tropical medicine and health 52(1):22 2024 [PMID: 38459581]
  30. Patel H, Minkah NK, Kumar S, Zanghi G, Schepis A, Goswami D, Armstrong J, Abatiyow BA, Betz W, Reynolds L, Camargo N, Sheikh AA, Kappe SHI. Malaria blood stage infection suppresses liver stage infection via host-induced interferons but not hepcidin Nature communications 15(1):2104 2024 [PMID: 38453916]
  31. Syeda MZ, Hong T, Huang C, Huang W, Mu Q. B cell memory: from generation to reactivation: a multipronged defense wall against pathogens Cell death discovery 10(1):117 2024 [PMID: 38453885]
  32. Bonet M, Babinska M, Buekens P, Goudar SS, Kampmann B, Knight M, Meaney-Delman D, Lamprianou S, Rivas FM, Stergachis A, Toscano CM, Bhatia J, Chamberlain S, Chaudhry U, Mills J, Serazin E, Short H, Steene A, Wahlen M, Oladapo OT. Maternal and perinatal health research during emerging and ongoing epidemic threats: a landscape analysis and expert consultation BMJ global health 9(3) 2024 [PMID: 38453249]
  33. Biswas S, Kumar R, Shalimar, Acharya SK. Viral hepatitis-induced acute liver failure Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2024 [PMID: 38451383]
  34. Okesanya OJ, Ogaya JB, Manirambona E, Anorue CO, Lucero-Prisno DE 3rd. Advancing Malaria Vaccination in Africa: Cameroon's Pioneering Effort and the Path Forward Environmental health insights 18:11786302241236013 2024 [PMID: 38449588]
  35. Tebben K, Yirampo S, Coulibaly D, Koné AK, Laurens MB, Stucke EM, Dembélé A, Tolo Y, Traoré K, Niangaly A, Berry AA, Kouriba B, Plowe CV, Doumbo OK, Lyke KE, Takala-Harrison S, Thera MA, Travassos MA, Serre D. Gene expression analyses reveal differences in children's response to malaria according to their age Nature communications 15(1):2021 2024 [PMID: 38448421]
  36. Chutiyami M, Saravanakumar P, Bello UM, Salihu D, Adeleye K, Kolo MA, Dawa KK, Hamina D, Bhandari P, Sulaiman SK, Sim J. Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies Infection 2024 [PMID: 38441731]
  37. Tay MZ, Tang W, Lee WC, Ong ASM, Novera W, Malleret B, Carissimo G, Chacko AM, El-Sahili A, Lescar J, Fan Y, McGready RM, Chu CS, Chan JKY, Ng LFP, Russell B, Nosten F, Rénia L. Functional and immunological mapping of domains of the reticulocyte binding protein, Plasmodium vivax PvRBP2a The Journal of infectious diseases 2024 [PMID: 38441336]
  38. Westercamp N, Osei-Tutu L, Schuerman L, Kariuki SK, Bollaerts A, Lee CK, Samuels AM, Ockenhouse C, Bii DK, Adjei S, Oneko M, Lievens M, Attobrah Sarfo MA, Atieno C, Bakari A, Sang T, Kotoh-Mortty MF, Otieno K, Roman F, Buabeng PBY, Ntiamoah Y, Ansong D, Agbenyega T, Ofori-Anyinam O. Could less be more? Accounting for fractional-dose regimens and different number of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine The Journal of infectious diseases 2024 [PMID: 38438123]
  39. Ma R, Salinas ND, Orr-Gonzalez S, Richardson B, Ouahes T, Torano H, Jenkins BJ, Dickey TH, Neal J, Duan J, Morrison RD, Gittis AG, Doritchamou JYA, Zaidi I, Lambert LE, Duffy PE, Tolia NH. Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine PLoS pathogens 20(3):e1011879 2024 [PMID: 38437239]
  40. Lee MSJ, Matsuo Dapaah J, Del Rosario Zorrilla C, Omatsu Y, Nagasawa T, Uemura S, Iwama A, Ishii KJ, Coban C. Acute malaria suppresses the B lymphocytic niche in the bone marrow through the alteration of CXCL12-abundant reticular cells International immunology 2024 [PMID: 38430523]
  41. Avalos-Padilla Y, Fernàndez-Busquets X. Nanotherapeutics against malaria: A decade of advancements in experimental models Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 16(2):e1943 2024 [PMID: 38426407]
  42. Dhage VD, Nagtode N. Health Problems Among Under-Five Age Group Children in Developing Countries: A Narrative Review Cureus 16(2):e55019 2024 [PMID: 38550476]
  43. Sy Thau N, Nguyen TK, Truong NV, Chu TH, Na SH, Moon RW, Lau YL, Nyunt MH, Park WS, Chun WJ, Lu F, Lee SK, Han JH, Han ET. Characterization of merozoite-specific thrombospondin-related anonymous protein (MTRAP) in Plasmodium vivax and P. knowlesi parasites Frontiers in cellular and infection microbiology 14:1354880 2024 [PMID: 38465236]
  44. Charital S, Lourdel A, Quansah N, Botté CY, Yamaryo-Botté Y. Monitoring of Lipid Fluxes Between Host and Plastid-Bearing Apicomplexan Parasites Methods in molecular biology (Clifton, N.J.) 2776:197-204 2024 [PMID: 38502506]
  45. Zida A, Guiguemde T, Sawadogo MP, Tchekounou C, Soulama I, Barry CS, Siribie M, Marks F, Sangaré I, Bamba S. Schistosomiasis in Burkina Faso: review on 60 years' research Annals of parasitology 69(3-4) 2024 [PMID: 38423519]
  46. Stanley CC, Zulu M, Msuku H, Phiri VS, Kazembe LN, Chinkhumba J, Mvalo T, Mathanga DP. Competing risks modeling of length of hospital stay enhances risk-stratification of patient care: application to under-five children hospitalized in Malawi Frontiers in epidemiology 3:1274776 2023 [PMID: 38455913]

Rickettsia prowazekii (Typhus fever)

  1. Hsueh YL, Chen HF, Chang MC, Yen TY, Su CL, Chiu HC, Hu HC, Chung YT, Shu PY, Yang SL. Epidemiology of Murine Typhus in Taiwan from 2013 to 2020 The American journal of tropical medicine and hygiene 110(4):768-778 2024 [PMID: 38471176]
  2. Weisbroth SH. The Use of Rabbits Used to Propagate Human Lice for Research Comparative medicine 2024 [PMID: 38449291]

Salmonella

  1. Huynh DT, Nolfi E, Medfai L, van Ulsen P, Jong WSP, Sijts AJAM, Luirink J. Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses Human vaccines & immunotherapeutics 20(1):2330768 2024 [PMID: 38517203]
  2. Naidu A, Garg V, Balakrishnan D, C R V, Sundararajan V, Lulu S S. Systems and Computational Screening identifies SRC and NKIRAS2 as Baseline Correlates of Risk (CoR) for Live Attenuated Oral Typhoid Vaccine (TY21a) associated Protection Molecular immunology 169:99-9109 2024 [PMID: 38552286]
  3. Marks F, Im J, Park SE, Pak GD, Jeon HJ, Wandji Nana LR, Phoba MF, Mbuyi-Kalonji L, Mogeni OD, Yeshitela B, Panzner U, Cruz Espinoza LM, Beyene T, Owusu-Ansah M, Twumasi-Ankrah S, Yeshambaw M, Alemu A, Adewusi OJ, Adekanmbi O, Higginson E, Adepoju A, Agbi S, Cakpo EG, Ogunleye VO, Tunda GN, Ikhimiukor OO, Mbuyamba J, Toy T, Agyapong FO, Osei I, Amuasi J, Razafindrabe TJL, Raminosoa TM, Nyirenda G, Randriamampionona N, Seo HW, Seo H, Siribie M, Carey ME, Owusu M, Meyer CG, Rakotozandrindrainy N, Sarpong N, Razafindrakalia M, Razafimanantsoa R, Ouedraogo M, Kim YJ, Lee J, Zellweger RM, Kang SSY, Park JY, Crump JA, Hardy L, Jacobs J, Garrett DO, Andrews JR, Poudyal N, Kim DR, Clemens JD, Baker SG, Kim JH, Dougan G, Sugimoto JD, Van Puyvelde S, Kehinde A, Popoola OA, Mogasale V, Breiman RF, MacWright WR, Aseffa A, Tadesse BT, Haselbeck A, Adu-Sarkodie Y, Teferi M, Bassiahi AS, Okeke IN, Lunguya-Metila O, Owusu-Dabo E, Rakotozandrindrainy R. Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study The Lancet. Global health 12(4):e599-e610 2024 [PMID: 38485427]
  4. Batool R, Qamar ZH, Salam RA, Yousafzai MT, Ashorn P, Qamar FN. Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis The Lancet. Global health 12(4):e589-e598 2024 [PMID: 38485426]
  5. Motz RN, Guo C, Sargun A, Walker GT, Sassone-Corsi M, Raffatellu M, Nolan EM. Conjugation to Native and Nonnative Triscatecholate Siderophores Enhances Delivery and Antibacterial Activity of a β-Lactam to Gram-Negative Bacterial Pathogens Journal of the American Chemical Society 146(11):7708-7722 2024 [PMID: 38457782]
  6. Long J, Zeng Y, Liang F, Liu N, Xi Y, Sun Y, Zhao X. Correction to: Transformed Salmonella typhimurium SL7207/pcDNA-CCOL2A1 as an orally administered DNA vaccine AMB Express 14(1):31 2024 [PMID: 38499902]
  7. Chileshe C, Shawa M, Phiri N, Ndebe J, Khumalo CS, Nakajima C, Kajihara M, Higashi H, Sawa H, Suzuki Y, Muleya W, Hang'ombe BM. Detection of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae from Diseased Broiler Chickens in Lusaka District, Zambia Antibiotics (Basel, Switzerland) 13(3) 2024 [PMID: 38534694]
  8. Kim JH, Tack B, Fiorino F, Pettini E, Marchello C, Jacobs J, Crump J, Marks F. Examining geospatial and temporal distribution of invasive non-typhoidal Salmonella disease occurrence in sub-Saharan Africa: a systematic review and modelling study BMJ open 14(3):e080501 2024 [PMID: 38485477]
  9. Salerno-Goncalves R, Chen H, Bafford AC, Izquierdo M, Hormazábal JC, Lagos R, Tettelin H, D'Mello A, Booth JS, Fasano A, Levine MM, Sztein MB. Early host immune responses in a human organoid-derived gallbladder monolayer to Salmonella Typhi strains from patients with acute and chronic infections: a comparative analysis Frontiers in immunology 15:1334762 2024 [PMID: 38533492]
  10. Xiong K, Deng L, Li Z, Gong H, Chen J, Huang M, Rao X, Cong Y. A TonB dependent transporter YncD of Salmonella enterica Serovar Typhi possesses vaccine potential World journal of microbiology & biotechnology 40(4):131 2024 [PMID: 38470539]
  11. Zhang L, Wu T, Wang F, Liu W, Zhao G, Zhang Y, Zhang Z, Shi Q. CheV enhances the virulence of Salmonella Enteritidis, and the Chev-deleted Salmonella vaccine provides immunity in mice BMC veterinary research 20(1):100 2024 [PMID: 38468314]
  12. Cobb J, Rawson J, Gonzalez N, Singer M, Kandeel F, Husseiny MI. Mechanism of Action of Oral Salmonella-Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice Vaccines 12(3) 2024 [PMID: 38543910]
  13. Ceyssens PJ, Mueller-Doblies D, Mattheus W. Design and Validation of RT-PCR Assays to Differentiate Salmonella Vaccine Strains from Wild-Type Field Isolates Veterinary sciences 11(3) 2024 [PMID: 38535854]
  14. Gasperini G, Massai L, De Simone D, Raso MM, Palmieri E, Alfini R, Rossi O, Ravenscroft N, Kuttel MM, Micoli F. O-Antigen decorations in Salmonella enterica play a key role in eliciting functional immune responses against heterologous serovars in animal models Frontiers in cellular and infection microbiology 14:1347813 2024 [PMID: 38487353]
  15. Bian X, Chen J, Chen X, Liu C, Ding J, Li M, Zhang X, Liu Q, Kong Q. Construction and Evaluation of an Efficient Live Attenuated Salmonella Choleraesuis Vaccine and Its Ability as a Vaccine Carrier to Deliver Heterologous Antigens Vaccines 12(3) 2024 [PMID: 38543883]
  16. Sivasankar C, Lloren KKS, Lee JH. Deciphering the Interrelationship of arnT Involved in Lipid-A Alteration with the Virulence of Salmonella Typhimurium International journal of molecular sciences 25(5) 2024 [PMID: 38474006]
  17. Barrow P. New Approaches to Tackling Intractable Issues in Infectious Disease Microorganisms 12(3) 2024 [PMID: 38543472]
  18. Dolatyabi S, Renu S, Schrock J, Renukaradhya GJ. Chitosan-nanoparticle-based oral Salmonella enteritidis subunit vaccine elicits cross-protection against Salmonella typhimurium in broilers Poultry science 103(5):103569 2024 [PMID: 38447310]

Shigella

  1. Vannice K, MacLennan CA, Long J, Steele AD. Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Shigella Surveillance Study Open forum infectious diseases 11(Suppl 1):S1-S5 2024 [PMID: 38532964]
  2. Atlas HE, Conteh B, Islam MT, Jere KC, Omore R, Sanogo D, Schiaffino F, Yousafzai MT, Ahmed N, Awuor AO, Badji H, Cornick J, Feutz E, Galagan SR, Haidara FC, Horne B, Hossen MI, Hotwani A, Houpt ER, Jallow AF, Karim M, Keita AM, Keita Y, Khanam F, Liu J, Malemia T, Manneh A, McGrath CJ, Nasrin D, Ndalama M, Ochieng JB, Ogwel B, Paredes Olortegui M, Zegarra Paredes LF, Pinedo Vasquez T, Platts-Mills JA, Qudrat-E-Khuda S, Qureshi S, Hasan Rajib MN, Rogawski McQuade ET, Sultana S, Tennant SM, Tickell KD, Witte D, Peñataro Yori P, Cunliffe NA, Hossain MJ, Kosek MN, Kotloff KL, Qadri F, Qamar FN, Tapia MD, Pavlinac PB. Diarrhea Case Surveillance in the Enterics for Global Health Shigella Surveillance Study: Epidemiologic Methods Open forum infectious diseases 11(Suppl 1):S6-S16 2024 [PMID: 38532963]
  3. Khanam F, Islam MT, Bhuiyan TR, Hossen MI, Rajib MNH, Haque S, Ireen M, Qudrat-E-Khuda S, Biswas PK, Bhuiyan MAI, Islam K, Rahman N, Alam Raz SMA, Mosharraf MP, Shawon Bhuiyan ME, Islam S, Ahmed D, Ahmmed F, Zaman K, Clemens JD, Qadri F. The Enterics for Global Health (EFGH) Shigella Surveillance Study in Bangladesh Open forum infectious diseases 11(Suppl 1):S76-S83 2024 [PMID: 38532962]
  4. Morozoff C, Ahmed N, Chinkhumba J, Islam MT, Jallow AF, Ogwel B, Zegarra Paredes LF, Sanogo D, Atlas HE, Badji H, Bar-Zeev N, Conteh B, Güimack Fajardo M, Feutz E, Haidara FC, Karim M, Mamby Keita A, Keita Y, Khanam F, Kosek MN, Kotloff KL, Maguire R, Mbutuka IS, Ndalama M, Ochieng JB, Okello C, Omore R, Perez Garcia KF, Qamar FN, Qudrat-E-Khuda S, Qureshi S, Rajib MNH, Shapiama Lopez WV, Sultana S, Witte D, Yousafzai MT, Awuor AO, Cunliffe NA, Jahangir Hossain M, Paredes Olortegui M, Tapia MD, Zaman K, Means AR. Quantifying the Cost of Shigella Diarrhea in the Enterics for Global Health (EFGH) Shigella Surveillance Study Open forum infectious diseases 11(Suppl 1):S41-S47 2024 [PMID: 38532961]
  5. Liu J, Garcia Bardales PF, Islam K, Jarju S, Juma J, Mhango C, Naumanga Q, Qureshi S, Sonye C, Ahmed N, Aziz F, Bhuiyan MTR, Charles M, Cunliffe NA, Abdou M, Galagan SR, Gitteh E, Guindo I, Jahangir Hossain M, Jabang AMJ, Jere KC, Kawonga F, Keita M, Keita NY, Kotloff KL, Shapiama Lopez WV, Munga S, Paredes Olortegui M, Omore R, Pavlinac PB, Qadri F, Qamar FN, Azadul Alam Raz SM, Riziki L, Schiaffino F, Stroup S, Traore SN, Pinedo Vasquez T, Yousafzai MT, Antonio M, Cornick JE, Kabir F, Khanam F, Kosek MN, Ochieng JB, Platts-Mills JA, Tennant SM, Houpt ER. Shigella Detection and Molecular Serotyping With a Customized TaqMan Array Card in the Enterics for Global Health (EFGH): Shigella Surveillance Study Open forum infectious diseases 11(Suppl 1):S34-S40 2024 [PMID: 38532960]
  6. Conteh B, Badji H, Jallow AF, Karim M, Manneh A, Keita B, Sarwar G, Ceesay BE, Jarju S, Jabang AMJ, Baldeh E, Ikumapayi UN, Secka O, Antonio M, Roca A, D'Alessandro U, Kotloff KL, Hossain MJ. The Enterics for Global Health (EFGH) Shigella Surveillance Study in The Gambia Open forum infectious diseases 11(Suppl 1):S84-S90 2024 [PMID: 38532959]
  7. Benedicto-Matambo P, Avolio LN, Badji H, Batool R, Khanam F, Munga S, Tapia MD, Peñataro Yori P, Awuor AO, Ceesay BE, Cornick J, Cunliffe NA, Garcia Bardales PF, Heaney CD, Hotwani A, Ireen M, Taufiqul Islam M, Jallow O, Kaminski RW, Shapiama Lopez WV, Maiden V, Ikumapayi UN, Nyirenda R, Ochieng JB, Omore R, Paredes Olortegui M, Pavlinac PB, Pisanic N, Qadri F, Qureshi S, Rahman N, Rogawski McQuade ET, Schiaffino F, Secka O, Sonye C, Sultana S, Timite D, Traore A, Yousafzai MT, Taufiqur Rahman Bhuiyan M, Jahangir Hossain M, Jere KC, Kosek MN, Kotloff KL, Qamar FN, Sow SO, Platts-Mills JA. Exploring Natural Immune Responses to Shigella Exposure Using Multiplex Bead Assays on Dried Blood Spots in High-Burden Countries: Protocol From a Multisite Diarrhea Surveillance Study Open forum infectious diseases 11(Suppl 1):S58-S64 2024 [PMID: 38532958]
  8. Babb C, Badji H, Bhuiyan MTR, Cornick J, Qureshi S, Sonye C, Shapiama Lopez WV, Adnan M, Atlas HE, Begum K, Brennhofer SA, Ceesay BE, Ceesay AK, Cunliffe NA, Garcia Bardales PF, Haque S, Horne B, Hossain MJ, Iqbal J, Islam MT, Islam S, Khanam F, Kotloff KL, Malemia T, Manzanares Villanueva K, Million GM, Munthali V, Ochieng JB, Ogwel B, Paredes Olortegui M, Omore R, Pavlinac PB, Platts-Mills JA, Sears KT, Secka O, Tennant SM, Peñataro Yori P, Yousafzai MT, Jere KC, Kosek MN, Munga S, Ikumapayi UN, Qadri F, Qamar FN, Rogawski McQuade ET. Evaluation of Fecal Inflammatory Biomarkers to Identify Bacterial Diarrhea Episodes: Systematic Review and Protocol for the Enterics for Global Health Shigella Surveillance Study Open forum infectious diseases 11(Suppl 1):S65-S75 2024 [PMID: 38532957]
  9. Dodd R, Awuor AO, Garcia Bardales PF, Khanam F, Mategula D, Onwuchekwa U, Sarwar G, Yousafzai MT, Ahmed N, Atlas HE, Amirul Islam Bhuiyan M, Colston JM, Conteh B, Diawara M, Dilruba N, Elwood S, Fatima I, Feutz E, Galagan SR, Haque S, Taufiqul Islam M, Karim M, Keita B, Kosek MN, Kotloff KL, Lefu C, Mballow M, Ndalama M, Ndeketa L, Ogwel B, Okonji C, Paredes Olortegui M, Pavlinac PB, Pinedo Vasquez T, Platts-Mills JA, Qadri F, Qureshi S, Rogawski McQuade ET, Sultana S, Traore MO, Cunliffe NA, Jahangir Hossain M, Omore R, Qamar FN, Tapia MD, Peñataro Yori P, Zaman K, McGrath CJ. Population Enumeration and Household Utilization Survey Methods in the Enterics for Global Health (EFGH): Shigella Surveillance Study Open forum infectious diseases 11(Suppl 1):S17-S24 2024 [PMID: 38532956]
  10. Keita AM, Doh S, Juma J, Nasrin D, Traoré A, Onwuchekwa U, Maguire R, Haidara FC, Sow SO, Kotloff KL, Tapia MD. The Enterics for Global Health (EFGH) Shigella Surveillance Study in Mali Open forum infectious diseases 11(Suppl 1):S107-S112 2024 [PMID: 38532954]
  11. Omore R, Awuor AO, Ogwel B, Okonji C, Sonye C, Oreso C, Akelo V, Amollo M, Ogudi I, Anyango RO, Audi M, Apondi E, Riziki L, Ambila L, Dilruba N, Muok E, Munga S, Ochieng JB, Kotloff KL. The Enterics for Global Health (EFGH) Shigella Surveillance Study in Kenya Open forum infectious diseases 11(Suppl 1):S91-S100 2024 [PMID: 38532953]
  12. Feutz E, Biswas PK, Ndeketa L, Ogwel B, Onwuchekwa U, Sarwar G, Sultana S, Peñataro Yori P, Acebedo A, Ahmed N, Ahmed I, Atlas HE, Awuor AO, Bhuiyan MAI, Conteh B, Diawara O, Elwood S, Fane M, Hossen MI, Ireen M, Jallow AF, Karim M, Kosek MN, Kotloff KL, Lefu C, Liu J, Maguire R, Qamar FN, Ndalama M, Ochieng JB, Okonji C, Paredes LFZ, Pavlinac PB, Perez K, Qureshi S, Schiaffino F, Traore M, Tickell KD, Wachepa R, Witte D, Cornick J, Jahangir Hossain M, Khanam F, Olortegui MP, Omore R, Sow SO, Yousafzai MT, Galagan SR. Data Management in Multicountry Consortium Studies: The Enterics For Global Health (EFGH) Shigella Surveillance Study Example Open forum infectious diseases 11(Suppl 1):S48-S57 2024 [PMID: 38532952]
  13. Ahmed N, Yousafzai MT, Naz Qamar F. The Enterics for Global Health (EFGH) Shigella Surveillance Study in Pakistan Open forum infectious diseases 11(Suppl 1):S113-S120 2024 [PMID: 38532950]
  14. Horne B, Badji H, Bhuiyan MTR, Romaina Cachique L, Cornick J, Hotwani A, Juma J, Ochieng JB, Abdou M, Apondi E, Atlas HE, Awuor AO, Baker KS, Ceesay BE, Charles M, Cunliffe NA, Feutz E, Galagan SR, Guindo I, Hossain MJ, Iqbal J, Jallow F, Keita NY, Khanam F, Kotloff KL, Maiden V, Manzanares Villanueva K, Mito O, Mosharraf MP, Nkeze J, Ikumapayi UN, Paredes Olortegui M, Pavlinac PB, Pinedo Vasquez T, Qadri F, Qamar FN, Qureshi S, Rahman N, Sangare A, Sen S, Peñataro Yori P, Yousafzai MT, Ahmed D, Jere KC, Kosek MN, Omore R, Permala-Booth J, Secka O, Tennant SM. Microbiological Methods Used in the Enterics for Global Health Shigella Surveillance Study Open forum infectious diseases 11(Suppl 1):S25-S33 2024 [PMID: 38532949]
  15. Chileshe C, Shawa M, Phiri N, Ndebe J, Khumalo CS, Nakajima C, Kajihara M, Higashi H, Sawa H, Suzuki Y, Muleya W, Hang'ombe BM. Detection of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae from Diseased Broiler Chickens in Lusaka District, Zambia Antibiotics (Basel, Switzerland) 13(3) 2024 [PMID: 38534694]
  16. Conti V, Rossi O, Clarkson KA, Mancini F, Nakakana UN, Sarakinou E, Callegaro A, Ferruzzi P, Acquaviva A, Arora AK, Marchetti E, Necchi F, Frenck RW Jr, Martin LB, Kaminski RW, Podda A, Micoli F. Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine NPJ vaccines 9(1):56 2024 [PMID: 38459072]
  17. Miles SL, Holt KE, Mostowy S. Recent advances in modelling Shigella infection Trends in microbiology 2024 [PMID: 38423917]
  18. Asato V, Bassal R, Meron-Sudai S, Goren S, Keinan-Boker L, MacLennan CA, Cohen D. IgG Serum Antibodies to Shigella sonnei Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven S. sonnei Shigellosis in Israeli Children and Adolescents Vaccines 12(3) 2024 [PMID: 38543873]

Variola major (Smallpox)

  1. Goldstein N, McLean C, Gaddah A, Doua J, Keshinro B, Bus-Jacobs L, Hendriks J, Luhn K, Robinson C, Douoguih M. Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial Human vaccines & immunotherapeutics 20(1):2327747 2024 [PMID: 38523332]
  2. Li Q, Chen Y, Zhang W, Li C, Tang D, Hua W, Hou F, Chen Z, Liu Y, Tian Y, Sun K, Xu X, Zeng Y, Xia F, Lu J, Wang Z. Mpox virus Clade IIb infected Cynomolgus macaques via mimic natural infection routes closely resembled human mpox infection Emerging microbes & infections 13(1):2332669 2024 [PMID: 38494777]
  3. Cheung DH, Chen S, Fang Y, Sun F, Zhang Q, Yu FY, Mo PKH, Wang Z. Influences of mpox disease perceptions, sources and contents of information exposure on mpox vaccine uptake among gay, bisexual, and other men who have sex with men in Hong Kong, China Vaccine 42(9):2337-2346 2024 [PMID: 38480102]
  4. Fresse A, Massy N, Fournier D, Pinel S, Beurrier M, Antoine ML, Petitpain N, Gillet P. Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic AIDS (London, England) 38(5):768-771 2024 [PMID: 38482909]
  5. Allard R, Leclerc P, Bergeron G, Cadieux G. Breakthrough cases of mpox: One-dose vaccination is associated with milder clinical manifestations Journal of infection and public health 17(4):676-680 2024 [PMID: 38461797]
  6. Sun Y, Nie W, Tian D, Ye Q. Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 171:105662 2024 [PMID: 38432097]
  7. Jacob-Dolan C, Ty D, Hope D, McMahan K, Liu J, Powers OC, Cotter CA, Sciacca M, Wu C, Borducchi E, Bouffard E, Richter H, Velasco J, Teow E, Boursiquot M, Cook A, Feliciano K, Yalley-Ogunro J, Seaman MS, Pessiant L, Lewis MG, Andersen H, Moss B, Barouch DH. Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques Science translational medicine 16(740):eadl4317 2024 [PMID: 38536937]
  8. Luo S, Jiao K, Zhang Y, Xu Y, Zhou J, Huang S, Li Y, Xiao Y, Ma W, He L, Ren X, Dai Z, Sun J, Li Q, Cheng F, Liang W. Behavioral Intention of Receiving Monkeypox Vaccination and Undergoing Monkeypox Testing and the Associated Factors Among Young Men Who Have Sex With Men in China: Large Cross-Sectional Study JMIR public health and surveillance 10:e47165 2024 [PMID: 38502181]
  9. Walsh-Buhi ML, Houghton RF, Valdez D, Walsh-Buhi ER. A theory-based assessment of mpox: Findings from a nationally representative survey of U.S. adults PloS one 19(3):e0299599 2024 [PMID: 38489274]
  10. Nitido AN, Balazs AB. mRNA-based monkeypox virus vaccine prevents disease in non-human primates Cell 187(6):1360-1362 2024 [PMID: 38490180]
  11. Grüner E, Grossegesse M, Stern D, Ober V, Eser TM, Reiling G, Stirner R, Ibarra G, Postel N, Conca R, Dächert C, Grifoni A, Sette A, Bogner J, Seybold U, Roider J. Mpox-specific immune responses elicited by vaccination or infection in people living with HIV The Journal of infectious diseases 2024 [PMID: 38478746]
  12. Lim SY, Jung YM, Kim Y, Kim G, Jeon J, Chin B, Kim MK. Adverse Reactions After Intradermal Vaccination With JYNNEOS for Mpox in Korea Journal of Korean medical science 39(8):e100 2024 [PMID: 38442725]
  13. Ramírez-Olivencia G, Velasco Arribas M, Vera García MM, Casabona J, Martínez MJ, Membrillo De Novales FJ. Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study) Open forum infectious diseases 11(3):ofae105 2024 [PMID: 38524223]
  14. Maqbool KU, Akhtar MT, Ayub S, Simran F, Malik J, Malik M, Zubair R, Mehmoodi A. Role of vaccination in patients with human monkeypox virus and its cardiovascular manifestations Annals of medicine and surgery (2012) 86(3):1506-1516 2024 [PMID: 38463133]
  15. Natami M, Gorgzadeh A, Gholipour A, Fatemi SN, Firouzeh N, Zokaei M, Mohammed Ali SH, Kheradjoo H, Sedighi S, Gholizadeh O, Kalavi S. An overview on mRNA-based vaccines to prevent monkeypox infection Journal of nanobiotechnology 22(1):86 2024 [PMID: 38429829]
  16. Zuo K, Gao W, Wu Z, Zhang L, Wang J, Yuan X, Li C, Xiang Q, Lu L, Liu H. Evolution of Virology: Science History through Milestones and Technological Advancements Viruses 16(3) 2024 [PMID: 38543740]
  17. Tarbouriech N, Burmeister WP, Bersch B, Iseni F. [Poxvirus-encoded DNA replication proteins: potential targets for antivirals] Virologie (Montrouge, France) 28(1):23-35 2024 [PMID: 38450665]
  18. Sookaromdee P, Wiwanitkit V. Smallpox Vaccination Discontinuation and Expansion Into an Endemic Area of Monkeypox: A Reanalysis of Available Data International journal of preventive medicine 15:1 2024 [PMID: 38487699]
  19. Mungmunpuntipantip R, Wiwanitkit V. Wanning Smallpox Vaccination, Decreased Population Immunity Rate and Increased Incidence of Monkeypox: Reappraisal on West African Situation International journal of preventive medicine 14:130 2023 [PMID: 38449690]
  20. Huang CC, Bashford A. Smallpox Geographies: vaccination, borders and Indigenous peoples in Australia's coastal north Medical history 68(1):22-41 2024 [PMID: 38494901]

Venezuelan equine encephalitis virus

  1. Comes JDG, Doets K, Zegers T, Kessler M, Slits I, Ballesteros NA, van de Weem NMP, Pouwels H, van Oers MM, van Hulten MCW, Langereis M, Pijlman GP. Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens Vaccine 42(11):2895-2908 2024 [PMID: 38521674]
  2. Fierro C, Weidenthaler H, Vidojkovic S, Schmidt D, Gafoor Z, Stroukova D, Zwiers S, Müller J, Volkmann A. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial Vaccine 42(10):2695-2706 2024 [PMID: 38494412]

Vibrio cholerae

  1. Xu H, Zou K, Dent J, Wiens KE, Malembaka EB, Bwire G, Okitayemba PW, Hampton LM, Azman AS, Lee EC. Enhanced cholera surveillance to improve vaccination campaign efficiency Nature medicine 30(4):1104-1110 2024 [PMID: 38443690]

Western equine encephalitis virus

  1. Fierro C, Weidenthaler H, Vidojkovic S, Schmidt D, Gafoor Z, Stroukova D, Zwiers S, Müller J, Volkmann A. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial Vaccine 42(10):2695-2706 2024 [PMID: 38494412]

Yersinia pestis (Plague)

  1. Tullius MV, Bowen RA, Back PS, Masleša-Galić S, Nava S, Horwitz MA. LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice mBio 15(4):e0018624 2024 [PMID: 38511933]
  2. Leblanc C, Kassié D, Ranaivoharimina M, Rakotomanana EFN, Mangahasimbola RT, Randrianarijaona A, Ramiandrasoa R, Nely AJ, Razafindraibe NP, Andriamandimby SF, Ranoaritiana DB, Rajaonarivony V, Randrianasolo L, Baril L, Mattern C, Ratovoson R, Guis H. Mixed methods to evaluate knowledge, attitudes and practices (KAP) towards rabies in central and remote communities of Moramanga district, Madagascar PLoS neglected tropical diseases 18(3):e0012064 2024 [PMID: 38551968]
  3. Guo X, Xin Y, Tong Z, Cao S, Zhang Y, Wu G, Chen H, Wang T, Song Y, Zhang Q, Yang R, Du Z. A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague PLoS pathogens 20(3):e1012129 2024 [PMID: 38547321]
  4. Bonet M, Babinska M, Buekens P, Goudar SS, Kampmann B, Knight M, Meaney-Delman D, Lamprianou S, Rivas FM, Stergachis A, Toscano CM, Bhatia J, Chamberlain S, Chaudhry U, Mills J, Serazin E, Short H, Steene A, Wahlen M, Oladapo OT. Maternal and perinatal health research during emerging and ongoing epidemic threats: a landscape analysis and expert consultation BMJ global health 9(3) 2024 [PMID: 38453249]
  5. Dubrovina VI, Yur'eva OV, Pyatidesyatnikova AB, Starovoitova TP, Balakhonov SV. Dynamics of Changes in the cAMP/cGMP Concentration Ratio in the Thymus and Spleen of Laboratory Mice during Vaccination against Plague and Tularemia against the Background of Immunomodulation Bulletin of experimental biology and medicine 176(4):472-476 2024 [PMID: 38492103]


** Click HERE to see the latest publications in this month.